XML 55 R37.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Consolidated Schedule of Investments (Unaudited) - Investments (Details) - USD ($) | Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022
--- | --- | --- | ---
Investments at cost |  | $ 766,774,000 | $ 759,182,000 |
Investments at fair value |  | 697,891,000 | 709,085,000 |
Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 694,503,000 | 716,077,000 |
Investments at fair value |  | 657,765,000 | 693,730,000 |
Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | 27,491,000 | 28,677,000 |
Investments at fair value |  | 8,307,000 | 1,132,000 | $ 0
Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  | 44,780,000 | 14,428,000 |
Investments at fair value |  | 31,819,000 | 14,223,000 | 0
Software Sector [Member] |  |  |  |
Investments at cost |  | 154,040,000 | 164,133,000 |
Investments at fair value |  | 151,043,000 | 160,749,000 |
Diagnostics Sector [Member] |  |  |  |
Investments at cost |  | 16,704,000 | 19,735,000 |
Investments at fair value |  | 13,701,000 | 19,701,000 |
Biotechnology Sector [Member] |  |  |  |
Investments at cost |  | 118,221,000 | 145,544,000 |
Investments at fair value |  | 97,562,000 | 117,781,000 |
Medical Device Sector [Member] |  |  |  |
Investments at cost |  | 213,564,000 | 147,064,000 |
Investments at fair value |  | 205,634,000 | 145,019,000 |
Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 8,918,000 |  |
Investments at fair value |  | 10,650,000 |  |
Communications Sector [Member] |  |  |  |
Investments at cost |  | 11,711,000 | 19,192,000 |
Investments at fair value |  | 14,763,000 | 22,188,000 |
Other Sustainability Sector [Member] |  |  |  |
Investments at cost |  | 66,151,000 | 98,906,000 |
Investments at fair value |  | 66,079,000 | 80,370,000 |
Other Healthcare Sector [Member] |  |  |  |
Investments at cost |  | 39,533,000 | 102,000 |
Investments at fair value |  | 40,144,000 | 1,366,000 |
Energy Efficiency [Member] |  |  |  |
Investments at cost |  | 9,818,000 | 111,000 |
Investments at fair value |  | 9,712,000 | 13,000 |
Networking Sector [Member] |  |  |  |
Investments at cost |  | 10,070,000 | 5,451,000 |
Investments at fair value |  | 9,827,000 | 5,297,000 |
Data Storage Sector [Member] |  |  |  |
Investments at cost |  | 417,000 | 417,000 |
Investments at fair value |  | 350,000 | 418,000 |
Internet and Media Sector [Member] |  |  |  |
Investments at cost |  | 329,000 | 329,000 |
Investments at fair value |  | 999,000 | 1,582,000 |
Power Management Sector [Member] |  |  |  |
Investments at cost |  | 0 | 1,585,000 |
Investments at fair value |  | 0 | 2,700,000 |
Semiconductor Sector [Member] |  |  |  |
Investments at cost |  | 45,000 | 45,000 |
Investments at fair value |  | 0 | 0 |
Software, Healthcare Information and Service [Member] |  |  |  |
Investments at cost |  | 51,750,000 | 50,899,000 |
Investments at fair value |  | 51,410,000 | $ 50,574,000 |
DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 15.00% |
Margin |  |  | 6.50% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.50% |
Maturity Date |  |  | Apr. 01, 2026 |
Principal Amount |  |  | $ 6,625,000 |
Investments at cost |  |  | 6,519,000 |
Investments at fair value |  |  | $ 6,176,000 |
DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 15.00% |
Margin |  |  | 6.50% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.50% |
Maturity Date |  |  | Apr. 01, 2026 |
Principal Amount |  |  | $ 6,116,000 |
Investments at cost |  |  | 6,018,000 |
Investments at fair value |  |  | 5,701,000 |
DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 455,000 |
Investments at fair value |  |  | $ 46,000 |
Number of Shares (in shares) |  |  | 516,732 |
DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 15.00% |
Margin |  |  | 6.50% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.50% |
Maturity Date |  |  | Aug. 01, 2026 |
Principal Amount |  |  | $ 2,548,000 |
Investments at cost |  |  | 2,507,000 |
Investments at fair value |  |  | $ 2,375,000 |
Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 6.00% |
Floor |  |  | 9.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.50% |
Maturity Date |  |  | Jun. 01, 2026 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,484,000 |
Investments at fair value |  |  | 2,484,000 |
Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 46,000 |
Investments at fair value |  |  | $ 12,000 |
Number of Shares (in shares) |  |  | 171,370 |
Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 6.00% |
Floor |  |  | 9.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.50% |
Maturity Date |  |  | Jun. 01, 2026 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,484,000 |
Investments at fair value |  |  | $ 2,484,000 |
Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 6.00% |
Floor |  |  | 9.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.50% |
Maturity Date |  |  | Jun. 01, 2026 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,968,000 |
Investments at fair value |  |  | 4,968,000 |
Evelo Biosciences, Inc. [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at fair value |  | 8,307,000 | $ 1,132,000 | 0
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 4.25% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.27% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 5,532,000 |
Investments at cost |  |  | 5,228,000 |
Investments at fair value |  |  | $ 222,000 |
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 4.25% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.27% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 8,298,000 |
Investments at cost |  |  | 7,867,000 |
Investments at fair value |  |  | $ 336,000 |
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 4.25% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.27% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 3,319,000 |
Investments at cost |  |  | 3,137,000 |
Investments at fair value |  |  | $ 133,000 |
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 4.25% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.27% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 3,319,000 |
Investments at cost |  |  | 3,137,000 |
Investments at fair value |  |  | $ 133,000 |
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 4.25% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.27% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 2,213,000 |
Investments at cost |  |  | 2,091,000 |
Investments at fair value |  |  | $ 88,000 |
Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 4.25% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.27% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 2,213,000 |
Investments at cost |  |  | 2,091,000 |
Investments at fair value |  |  | 88,000 |
Aulea Medical, Inc. [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at fair value |  | 0 | 0 | 0
Better Place Forests Co. [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at fair value |  | $ 0 | $ 7,993,000 | 0
Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.25% |
Margin |  |  | 3.75% |
Floor |  |  | 12.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 1.85% |
Maturity Date |  |  | Aug. 01, 2029 |
Principal Amount |  |  | $ 3,547,000 |
Investments at cost |  |  | 3,585,000 |
Investments at fair value |  |  | $ 3,339,000 |
Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 12.25% |
Margin |  |  | 3.75% |
Floor |  |  | 12.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 1.85% |
Maturity Date |  |  | Aug. 01, 2029 |
Principal Amount |  |  | $ 1,773,000 |
Investments at cost |  |  | 1,750,000 |
Investments at fair value |  |  | 1,630,000 |
Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 214,000 |
Investments at fair value |  |  | $ 318,000 |
Number of Shares (in shares) |  |  | 7,404 |
Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 3.50% |
Floor |  |  | 11.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Sep. 01, 2027 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,757,000 |
Investments at fair value |  |  | 4,757,000 |
Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 152,000 |
Investments at fair value |  |  | $ 135,000 |
Number of Shares (in shares) |  |  | 93,336 |
Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 11.50% | 12.00% |
Margin |  | 3.50% | 3.50% |
Floor |  | 11.50% | 11.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Sep. 01, 2027 | Sep. 01, 2027 |
Principal Amount |  | $ 2,500,000 | $ 2,500,000 |
Investments at cost |  | 2,468,000 | 2,454,000 |
Investments at fair value |  | $ 2,468,000 | $ 2,454,000 |
Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 11.50% | 12.00% |
Margin |  | 3.50% | 3.50% |
Floor |  | 11.50% | 11.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Sep. 01, 2027 | Sep. 01, 2027 |
Principal Amount |  | $ 2,500,000 | $ 2,500,000 |
Investments at cost |  | 2,468,000 | 2,454,000 |
Investments at fair value |  | $ 2,468,000 | $ 2,454,000 |
VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.25% |
Margin |  |  | 3.75% |
Floor |  |  | 12.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Jan. 01, 2029 |
Principal Amount |  |  | $ 15,000,000 |
Investments at cost |  |  | 14,675,000 |
Investments at fair value |  |  | 14,675,000 |
VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 432,000 |
Investments at fair value |  |  | $ 379,000 |
Number of Shares (in shares) |  |  | 4,109 |
VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 12.25% |
Margin |  |  | 3.75% |
Floor |  |  | 12.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Jan. 01, 2029 |
Principal Amount |  |  | $ 10,000,000 |
Investments at cost |  |  | 9,784,000 |
Investments at fair value |  |  | $ 9,784,000 |
VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 12.25% |
Margin |  |  | 3.75% |
Floor |  |  | 12.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Jan. 01, 2029 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,892,000 |
Investments at fair value |  |  | $ 4,892,000 |
VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 12.25% |
Margin |  |  | 3.75% |
Floor |  |  | 12.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Jan. 01, 2029 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,446,000 |
Investments at fair value |  |  | $ 2,446,000 |
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.50% |
Margin |  |  | 5.00% |
Floor |  |  | 5.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Mar. 01, 2027 |
Principal Amount |  |  | $ 2,000,000 |
Investments at cost |  |  | 1,421,000 |
Investments at fair value |  |  | $ 1,421,000 |
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.50% |
Margin |  |  | 5.00% |
Floor |  |  | 5.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Mar. 01, 2027 |
Principal Amount |  |  | $ 3,000,000 |
Investments at cost |  |  | 2,131,000 |
Investments at fair value |  |  | 2,131,000 |
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 2,947,000 |
Investments at fair value |  |  | $ 2,259,000 |
Number of Shares (in shares) |  |  | 1,312,500 |
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 3.50% |
Floor |  |  | 10.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 7.78% |
Maturity Date |  |  | Feb. 01, 2028 |
Principal Amount |  |  | $ 2,813,000 |
Investments at cost |  |  | 2,813,000 |
Investments at fair value |  |  | $ 2,813,000 |
Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 3.50% |
Floor |  |  | 10.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 7.78% |
Maturity Date |  |  | Feb. 01, 2028 |
Principal Amount |  |  | $ 2,813,000 |
Investments at cost |  |  | 2,813,000 |
Investments at fair value |  |  | $ 2,813,000 |
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Apr. 01, 2026 |
Principal Amount |  |  | $ 10,000,000 |
Investments at cost |  |  | 9,895,000 |
Investments at fair value |  |  | 9,895,000 |
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 273,000 |
Investments at fair value |  |  | $ 13,000 |
Number of Shares (in shares) |  |  | 639,918 |
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Apr. 01, 2026 |
Principal Amount |  |  | $ 10,000,000 |
Investments at cost |  |  | 9,895,000 |
Investments at fair value |  |  | $ 9,895,000 |
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Apr. 01, 2026 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,947,000 |
Investments at fair value |  |  | $ 4,947,000 |
Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Apr. 01, 2026 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,947,000 |
Investments at fair value |  |  | 4,947,000 |
BrightInsight, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 167,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 85,066 |
BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Aug. 01, 2027 |
Principal Amount |  |  | $ 7,000,000 |
Investments at cost |  |  | 6,684,000 |
Investments at fair value |  |  | $ 6,684,000 |
BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Aug. 01, 2027 |
Principal Amount |  |  | $ 3,500,000 |
Investments at cost |  |  | 3,463,000 |
Investments at fair value |  |  | $ 3,463,000 |
BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Aug. 01, 2027 |
Principal Amount |  |  | $ 3,500,000 |
Investments at cost |  |  | 3,463,000 |
Investments at fair value |  |  | $ 3,463,000 |
BrightInsight, Inc. [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Apr. 01, 2028 |
Principal Amount |  |  | $ 2,750,000 |
Investments at cost |  |  | 2,710,000 |
Investments at fair value |  |  | $ 2,710,000 |
Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Nov. 01, 2026 |
Principal Amount |  |  | $ 3,500,000 |
Investments at cost |  |  | 3,469,000 |
Investments at fair value |  |  | $ 1,574,000 |
Robin Healthcare, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Nov. 01, 2026 |
Principal Amount |  |  | $ 3,500,000 |
Investments at cost |  |  | 3,563,000 |
Investments at fair value |  |  | $ 1,617,000 |
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 6.00% |
Floor |  |  | 9.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Jun. 01, 2026 |
Principal Amount |  |  | $ 6,250,000 |
Investments at cost |  |  | 6,218,000 |
Investments at fair value |  |  | $ 6,218,000 |
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 6.00% |
Floor |  |  | 9.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Jun. 01, 2026 |
Principal Amount |  |  | $ 6,250,000 |
Investments at cost |  |  | 6,218,000 |
Investments at fair value |  |  | 6,218,000 |
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 47,000 |
Investments at fair value |  |  | $ 61,000 |
Number of Shares (in shares) |  |  | 1,991 |
Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 6.00% |
Floor |  |  | 9.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Jun. 01, 2026 |
Principal Amount |  |  | $ 6,250,000 |
Investments at cost |  |  | 6,218,000 |
Investments at fair value |  |  | $ 6,218,000 |
Parse Biosciences, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 11.75% |
Margin |  |  | 3.25% |
Floor |  |  | 11.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,633,000 |
Investments at fair value |  |  | 4,633,000 |
Parse Biosciences, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 166,000 |
Investments at fair value |  |  | $ 166,000 |
Number of Shares (in shares) |  |  | 184,253 |
Parse Biosciences, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 11.75% |
Margin |  |  | 3.25% |
Floor |  |  | 11.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,884,000 |
Investments at fair value |  |  | 4,884,000 |
Parse Biosciences, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 70,000 |
Investments at fair value |  |  | $ 70,000 |
Number of Shares (in shares) |  |  | 32,244 |
Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 311,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 117 |
Magnolia Medical Technologies, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 194,000 |
Investments at fair value |  |  | $ 368,000 |
Number of Shares (in shares) |  |  | 809,931 |
Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.50% |
Margin |  |  | 5.00% |
Floor |  |  | 12.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Mar. 01, 2027 |
Principal Amount |  |  | $ 10,000,000 |
Investments at cost |  |  | 9,885,000 |
Investments at fair value |  |  | 9,885,000 |
Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 115,000 |
Investments at fair value |  |  | $ 2,000 |
Number of Shares (in shares) |  |  | 84,037 |
Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.50% |
Margin |  |  | 5.00% |
Floor |  |  | 12.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Mar. 01, 2027 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,942,000 |
Investments at fair value |  |  | $ 4,942,000 |
Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 13.50% |
Margin |  |  | 5.00% |
Floor |  |  | 12.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Mar. 01, 2027 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,942,000 |
Investments at fair value |  |  | 4,942,000 |
Meditrina, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 83,000 |
Investments at fair value |  |  | $ 93,000 |
Number of Shares (in shares) |  |  | 233,993 |
Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.50% | 13.25% |
Margin |  | 4.75% | 4.75% |
Floor |  | 8.50% | 8.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Jan. 01, 2027 | Jan. 01, 2027 |
Principal Amount |  | $ 3,750,000 | $ 3,750,000 |
Investments at cost |  | 3,735,000 | 3,722,000 |
Investments at fair value |  | $ 3,735,000 | 3,722,000 |
Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 103,000 |
Investments at fair value |  |  | $ 215,000 |
Number of Shares (in shares) |  |  | 34,410 |
Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.50% | 13.25% |
Margin |  | 4.75% | 4.75% |
Floor |  | 8.50% | 8.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Jan. 01, 2027 | Jan. 01, 2027 |
Principal Amount |  | $ 3,750,000 | $ 3,750,000 |
Investments at cost |  | 3,735,000 | 3,722,000 |
Investments at fair value |  | $ 3,735,000 | $ 3,722,000 |
Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 13.00% | 13.75% |
Margin |  | 5.25% | 5.25% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Jan. 01, 2027 | Jan. 01, 2027 |
Principal Amount |  | $ 5,000,000 | $ 5,000,000 |
Investments at cost |  | 4,964,000 | 4,943,000 |
Investments at fair value |  | $ 4,964,000 | $ 4,943,000 |
Scientia Vascular, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 13.00% | 13.75% |
Margin |  | 5.25% | 5.25% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Jan. 01, 2027 | Jan. 01, 2027 |
Principal Amount |  | $ 5,000,000 | $ 5,000,000 |
Investments at cost |  | 4,937,000 | 4,900,000 |
Investments at fair value |  | 4,937,000 | $ 4,900,000 |
Engage3, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.50% |
Maturity Date |  |  | Jul. 01, 2027 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,728,000 |
Investments at fair value |  |  | $ 3,728,000 |
Engage3, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.50% |
Maturity Date |  |  | Jul. 01, 2027 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,728,000 |
Investments at fair value |  |  | $ 3,728,000 |
New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 15.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.33% |
Maturity Date |  |  | Dec. 01, 2026 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,685,000 |
Investments at fair value |  |  | 3,685,000 |
New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 81,000 |
Investments at fair value |  |  | $ 72,000 |
Number of Shares (in shares) |  |  | 400,000 |
New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 15.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.33% |
Maturity Date |  |  | Dec. 01, 2026 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,685,000 |
Investments at fair value |  |  | 3,685,000 |
Kate Farms, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 102,000 |
Investments at fair value |  |  | $ 1,366,000 |
Number of Shares (in shares) |  |  | 82,965 |
HIMV LLC [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at fair value |  | $ 6,230,000 | $ 6,230,000 | 0
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 10.25% | 12.00% |
Margin |  | 2.75% | 3.50% |
Floor |  | 9.25% | 8.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 5.50% |
Maturity Date |  | Mar. 01, 2029 | Oct. 01, 2024 |
Principal Amount |  | $ 5,000,000 | $ 3,750,000 |
Investments at cost |  | 4,820,000 | 3,738,000 |
Investments at fair value |  | $ 4,820,000 | 3,738,000 |
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 69,000 |
Investments at fair value |  |  | $ 229,000 |
Number of Shares (in shares) |  |  | 145,483 |
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 10.25% | 12.00% |
Margin |  | 2.75% | 3.50% |
Floor |  | 9.25% | 8.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 5.50% |
Maturity Date |  | Mar. 01, 2029 | Oct. 01, 2024 |
Principal Amount |  | $ 5,000,000 | $ 3,750,000 |
Investments at cost |  | 4,941,000 | 3,738,000 |
Investments at fair value |  | $ 4,941,000 | $ 3,738,000 |
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 10.25% | 12.00% |
Margin |  | 2.75% | 3.50% |
Floor |  | 9.25% | 8.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 5.50% |
Maturity Date |  | Mar. 01, 2029 | Oct. 01, 2024 |
Principal Amount |  | $ 4,000,000 | $ 1,875,000 |
Investments at cost |  | 3,952,000 | 1,866,000 |
Investments at fair value |  | $ 3,952,000 | $ 1,866,000 |
Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 3.50% |
Floor |  |  | 8.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.50% |
Maturity Date |  |  | Oct. 01, 2024 |
Principal Amount |  |  | $ 1,875,000 |
Investments at cost |  |  | 1,866,000 |
Investments at fair value |  |  | 1,866,000 |
Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 178,000 |
Investments at fair value |  |  | $ 246,000 |
Number of Shares (in shares) |  |  | 110,402 |
MicroTransponder, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.25% | 12.25% |
Margin |  | 3.75% | 3.75% |
Floor |  | 12.25% | 12.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.50% | 3.50% |
Maturity Date |  | Jan. 01, 2029 | Jan. 01, 2029 |
Principal Amount |  | $ 3,750,000 | $ 3,750,000 |
Investments at cost |  | 3,699,000 | 3,689,000 |
Investments at fair value |  | $ 3,699,000 | 3,689,000 |
MicroTransponder, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 47,000 |
Investments at fair value |  |  | $ 47,000 |
Number of Shares (in shares) |  |  | 103,172 |
MicroTransponder, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.25% | 12.25% |
Margin |  | 3.75% | 3.75% |
Floor |  | 12.25% | 12.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.50% | 3.50% |
Maturity Date |  | Jan. 01, 2029 | Jan. 01, 2029 |
Principal Amount |  | $ 3,750,000 | $ 3,750,000 |
Investments at cost |  | 3,699,000 | 3,689,000 |
Investments at fair value |  | 3,699,000 | 3,689,000 |
Revinate Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 44,000 |
Investments at fair value |  |  | $ 91,000 |
Number of Shares (in shares) |  |  | 682,034 |
Nexii Building Solutions, Inc [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at fair value |  | $ 8,547,000 | $ 0 |
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 15.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Mar. 31, 2024 |
Principal Amount |  |  | $ 8,425,000 |
Investments at cost |  |  | 8,353,000 |
Investments at fair value |  |  | $ 4,549,000 |
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 15.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Mar. 31, 2024 |
Principal Amount |  |  | $ 8,425,000 |
Investments at cost |  |  | 8,229,000 |
Investments at fair value |  |  | 4,481,000 |
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 490,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 215,171 |
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 15.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Mar. 31, 2024 |
Principal Amount |  |  | $ 8,425,000 |
Investments at cost |  |  | 8,229,000 |
Investments at fair value |  |  | $ 4,481,000 |
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 15.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Mar. 31, 2024 |
Principal Amount |  |  | $ 5,617,000 |
Investments at cost |  |  | 5,480,000 |
Investments at fair value |  |  | $ 2,984,000 |
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  |  | 15.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Mar. 31, 2024 |
Principal Amount |  |  | $ 5,617,000 |
Investments at cost |  |  | 5,480,000 |
Investments at fair value |  |  | $ 2,984,000 |
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  |  | 15.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 0.00% |
Maturity Date |  |  | Mar. 31, 2024 |
Principal Amount |  |  | $ 735,000 |
Investments at cost |  |  | 726,000 |
Investments at fair value |  |  | $ 395,000 |
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate |  |  | 15.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 0.00% |
Maturity Date |  |  | Mar. 31, 2024 |
Principal Amount |  |  | $ 586,000 |
Investments at cost |  |  | 578,000 |
Investments at fair value |  |  | $ 315,000 |
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate |  |  | 15.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 0.00% |
Maturity Date |  |  | Mar. 31, 2024 |
Principal Amount |  |  | $ 292,000 |
Investments at cost |  |  | 288,000 |
Investments at fair value |  |  | $ 157,000 |
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Nine [Member] |  |  |  |
Cash Rate |  |  | 15.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 0.00% |
Maturity Date |  |  | Mar. 31, 2024 |
Principal Amount |  |  | $ 290,000 |
Investments at cost |  |  | 286,000 |
Investments at fair value |  |  | $ 156,000 |
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Ten [Member] |  |  |  |
Cash Rate |  |  | 15.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 0.00% |
Maturity Date |  |  | Mar. 31, 2024 |
Principal Amount |  |  | $ 174,000 |
Investments at cost |  |  | 172,000 |
Investments at fair value |  |  | $ 93,000 |
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eleven [Member] |  |  |  |
Cash Rate |  |  | 15.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 0.00% |
Maturity Date |  |  | Mar. 31, 2024 |
Principal Amount |  |  | $ 802,000 |
Investments at cost |  |  | 791,000 |
Investments at fair value |  |  | $ 431,000 |
Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Twelve [Member] |  |  |  |
Cash Rate |  |  | 15.50% |
Margin |  |  | 7.00% |
Floor |  |  | 10.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 0.00% |
Maturity Date |  |  | Mar. 31, 2024 |
Principal Amount |  |  | $ 1,091,000 |
Investments at cost |  |  | 1,083,000 |
Investments at fair value |  |  | $ 590,000 |
CAMP NYC, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 15.75% |
Margin |  |  | 7.25% |
Floor |  |  | 10.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | May 01, 2026 |
Principal Amount |  |  | $ 3,383,000 |
Investments at cost |  |  | 3,356,000 |
Investments at fair value |  |  | 3,356,000 |
CAMP NYC, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 22,000 |
Investments at fair value |  |  | $ 27,000 |
Number of Shares (in shares) |  |  | 75,997 |
LiquiGlide, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 39,000 |
Investments at fair value |  |  | $ 50,000 |
Number of Shares (in shares) |  |  | 61,359 |
Lyrical Foods, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 3.50% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 1.00% |
Maturity Date |  |  | Sep. 01, 2027 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,591,000 |
Investments at fair value |  |  | $ 2,429,000 |
Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 3.50% |
Floor |  |  | 11.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Oct. 01, 2028 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,779,000 |
Investments at fair value |  |  | $ 4,779,000 |
Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 3.50% |
Floor |  |  | 11.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Oct. 01, 2028 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,915,000 |
Investments at fair value |  |  | 4,915,000 |
Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 223,000 |
Investments at fair value |  |  | $ 247,000 |
Number of Shares (in shares) |  |  | 948,275 |
Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 3.50% |
Floor |  |  | 11.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Oct. 01, 2028 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,915,000 |
Investments at fair value |  |  | $ 4,915,000 |
Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 3.50% |
Floor |  |  | 11.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Oct. 01, 2028 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,915,000 |
Investments at fair value |  |  | 4,915,000 |
Imunon, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 65,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 19,671 |
Onkos Surgical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 10.75% |  |
Margin |  | 3.25% |  |
Floor |  | 10.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2030 |  |
Principal Amount |  | $ 10,000,000 |  |
Investments at cost |  | 9,818,000 |  |
Investments at fair value |  | $ 9,818,000 |  |
Onkos Surgical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 10.75% |  |
Margin |  | 3.25% |  |
Floor |  | 10.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2030 |  |
Principal Amount |  | $ 10,000,000 |  |
Investments at cost |  | 9,845,000 |  |
Investments at fair value |  | $ 9,845,000 |  |
Onkos Surgical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 10.75% |  |
Margin |  | 3.25% |  |
Floor |  | 10.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2030 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,923,000 |  |
Investments at fair value |  | $ 4,923,000 |  |
Onkos Surgical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 10.75% |  |
Margin |  | 3.25% |  |
Floor |  | 10.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2030 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,923,000 |  |
Investments at fair value |  | 4,923,000 |  |
SIGNiX, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 225,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 186,235 |
Clara Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.50% |
Maturity Date |  |  | Aug. 01, 2025 |
Principal Amount |  |  | $ 1,667,000 |
Investments at cost |  |  | 1,656,000 |
Investments at fair value |  |  | 1,656,000 |
Clara Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 29,000 |
Investments at fair value |  |  | $ 122,000 |
Number of Shares (in shares) |  |  | 46,745 |
Clara Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.50% |
Maturity Date |  |  | Aug. 01, 2025 |
Principal Amount |  |  | $ 1,583,000 |
Investments at cost |  |  | 1,573,000 |
Investments at fair value |  |  | 1,573,000 |
Elligo Health Research, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 192,000 |
Investments at fair value |  |  | $ 99,000 |
Number of Shares (in shares) |  |  | 652,250 |
Elligo Health Research, Inc [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 3.50% |
Floor |  |  | 11.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Oct. 01, 2027 |
Principal Amount |  |  | $ 10,000,000 |
Investments at cost |  |  | 9,656,000 |
Investments at fair value |  |  | $ 9,656,000 |
Elligo Health Research, Inc [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 3.50% |
Floor |  |  | 11.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Oct. 01, 2027 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,925,000 |
Investments at fair value |  |  | $ 4,925,000 |
Elligo Health Research, Inc [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 3.50% |
Floor |  |  | 11.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Oct. 01, 2027 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,925,000 |
Investments at fair value |  |  | $ 4,925,000 |
Elligo Health Research, Inc [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 12.00% |
Margin |  |  | 3.50% |
Floor |  |  | 11.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Oct. 01, 2027 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,925,000 |
Investments at fair value |  |  | $ 4,925,000 |
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.25% |
Maturity Date |  |  | Oct. 31, 2023 |
Principal Amount |  |  | $ 5,752,000 |
Investments at cost |  |  | 5,752,000 |
Investments at fair value |  |  | 5,018,000 |
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 9,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 1,224,752 |
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.25% |
Maturity Date |  |  | Oct. 31, 2023 |
Principal Amount |  |  | $ 2,301,000 |
Investments at cost |  |  | 2,301,000 |
Investments at fair value |  |  | 2,007,000 |
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 188,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 12,618 |
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.25% |
Maturity Date |  |  | Oct. 31, 2023 |
Principal Amount |  |  | $ 2,876,000 |
Investments at cost |  |  | 2,876,000 |
Investments at fair value |  |  | $ 2,509,000 |
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.25% |
Maturity Date |  |  | Oct. 31, 2023 |
Principal Amount |  |  | $ 3,451,000 |
Investments at cost |  |  | 3,451,000 |
Investments at fair value |  |  | $ 3,011,000 |
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.25% |
Maturity Date |  |  | Oct. 31, 2023 |
Principal Amount |  |  | $ 2,876,000 |
Investments at cost |  |  | 2,876,000 |
Investments at fair value |  |  | $ 2,510,000 |
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.25% |
Maturity Date |  |  | Oct. 31, 2023 |
Principal Amount |  |  | $ 2,876,000 |
Investments at cost |  |  | 2,876,000 |
Investments at fair value |  |  | $ 2,510,000 |
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.25% |
Maturity Date |  |  | Oct. 31, 2023 |
Principal Amount |  |  | $ 5,752,000 |
Investments at cost |  |  | 5,752,000 |
Investments at fair value |  |  | $ 5,018,000 |
NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.25% |
Maturity Date |  |  | Oct. 31, 2023 |
Principal Amount |  |  | $ 2,876,000 |
Investments at cost |  |  | 2,876,000 |
Investments at fair value |  |  | 2,510,000 |
KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 50,000 |
Investments at fair value |  |  | $ 53,000 |
Number of Shares (in shares) |  |  | 48,076 |
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Aug. 01, 2026 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,959,000 |
Investments at fair value |  |  | 4,959,000 |
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 123,000 |
Investments at fair value |  |  | $ 135,000 |
Number of Shares (in shares) |  |  | 309,208 |
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Aug. 01, 2026 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,959,000 |
Investments at fair value |  |  | $ 4,959,000 |
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Aug. 01, 2026 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,959,000 |
Investments at fair value |  |  | $ 4,959,000 |
Slingshot Aerospace, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 14.25% |
Margin |  |  | 5.75% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Aug. 01, 2026 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,959,000 |
Investments at fair value |  |  | 4,959,000 |
Swift Health Systems Inc. [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at fair value |  | $ 17,042,000 | $ 0 |
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 5.25% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jul. 01, 2027 |
Principal Amount |  |  | $ 3,500,000 |
Investments at cost |  |  | 3,467,000 |
Investments at fair value |  |  | 3,467,000 |
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 71,000 |
Investments at fair value |  |  | $ 1,000 |
Number of Shares (in shares) |  |  | 135,484 |
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 5.25% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jul. 01, 2027 |
Principal Amount |  |  | $ 3,500,000 |
Investments at cost |  |  | 3,467,000 |
Investments at fair value |  |  | $ 3,467,000 |
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 5.25% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jul. 01, 2027 |
Principal Amount |  |  | $ 3,500,000 |
Investments at cost |  |  | 3,456,000 |
Investments at fair value |  |  | $ 3,456,000 |
Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 13.75% |
Margin |  |  | 5.25% |
Floor |  |  | 9.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jul. 01, 2027 |
Principal Amount |  |  | $ 3,500,000 |
Investments at cost |  |  | 3,456,000 |
Investments at fair value |  |  | $ 3,456,000 |
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 15.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.75% |
Maturity Date |  |  | Apr. 01, 2026 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,959,000 |
Investments at fair value |  |  | 4,959,000 |
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 214,000 |
Investments at fair value |  |  | $ 340,000 |
Number of Shares (in shares) |  |  | 681 |
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 15.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.75% |
Maturity Date |  |  | Apr. 01, 2026 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,479,000 |
Investments at fair value |  |  | $ 2,479,000 |
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 15.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.75% |
Maturity Date |  |  | May 01, 2026 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,956,000 |
Investments at fair value |  |  | $ 4,956,000 |
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 15.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.75% |
Maturity Date |  |  | May 01, 2026 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,478,000 |
Investments at fair value |  |  | $ 2,478,000 |
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 11.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.75% |
Maturity Date |  |  | Dec. 01, 2026 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,934,000 |
Investments at fair value |  |  | $ 4,934,000 |
Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 11.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.75% |
Maturity Date |  |  | Dec. 01, 2026 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,467,000 |
Investments at fair value |  |  | 2,467,000 |
Medsphere Systems Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 60,000 |
Investments at fair value |  |  | $ 108,000 |
Number of Shares (in shares) |  |  | 7,097,792 |
Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.32% | 13.32% |
Margin |  | 4.82% | 4.82% |
Floor |  | 9.25% | 9.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 10.36% | 10.36% |
Maturity Date |  | Jul. 01, 2025 | Jul. 01, 2025 |
Principal Amount |  | $ 3,187,000 | $ 3,960,000 |
Investments at cost |  | 3,168,000 | 3,923,000 |
Investments at fair value |  | $ 3,168,000 | 3,923,000 |
Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 221,000 |
Investments at fair value |  |  | $ 206,000 |
Number of Shares (in shares) |  |  | 7,972,222 |
Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.32% | 13.32% |
Margin |  | 4.82% | 4.82% |
Floor |  | 9.25% | 9.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 10.36% | 10.36% |
Maturity Date |  | Jul. 01, 2025 | Jul. 01, 2025 |
Principal Amount |  | $ 3,187,000 | $ 3,960,000 |
Investments at cost |  | 3,168,000 | 3,923,000 |
Investments at fair value |  | $ 3,168,000 | 3,923,000 |
Mustang Bio, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 146,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 16,611 |
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 11.75% | 12.00% |
Margin |  | 3.50% | 3.50% |
Floor |  | 11.75% | 11.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 8.00% | 8.00% |
Maturity Date |  | Sep. 01, 2027 | Sep. 01, 2027 |
Principal Amount |  | $ 2,500,000 | $ 2,500,000 |
Investments at cost |  | 2,480,000 | 2,297,000 |
Investments at fair value |  | $ 2,480,000 | 2,297,000 |
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 275,000 |
Investments at fair value |  |  | $ 269,000 |
Number of Shares (in shares) |  |  | 2,637,043 |
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 11.75% | 12.00% |
Margin |  | 3.50% | 3.50% |
Floor |  | 11.75% | 11.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 8.00% | 8.00% |
Maturity Date |  | Sep. 01, 2027 | Sep. 01, 2027 |
Principal Amount |  | $ 2,500,000 | $ 2,500,000 |
Investments at cost |  | 2,480,000 | 2,473,000 |
Investments at fair value |  | $ 2,480,000 | $ 2,473,000 |
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 11.75% | 12.00% |
Margin |  | 3.50% | 3.50% |
Floor |  | 11.75% | 11.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 8.00% | 8.00% |
Maturity Date |  | Sep. 01, 2027 | Sep. 01, 2027 |
Principal Amount |  | $ 5,000,000 | $ 5,000,000 |
Investments at cost |  | 4,961,000 | 4,946,000 |
Investments at fair value |  | $ 4,961,000 | $ 4,946,000 |
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 11.75% | 12.00% |
Margin |  | 3.50% | 3.50% |
Floor |  | 11.75% | 11.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 8.00% | 8.00% |
Maturity Date |  | Sep. 01, 2027 | Sep. 01, 2027 |
Principal Amount |  | $ 5,000,000 | $ 5,000,000 |
Investments at cost |  | 4,961,000 | 4,946,000 |
Investments at fair value |  | $ 4,961,000 | $ 4,946,000 |
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 8.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,714,000 |  |
Investments at fair value |  | $ 3,714,000 |  |
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 8.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,714,000 |  |
Investments at fair value |  | $ 3,714,000 |  |
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 8.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,714,000 |  |
Investments at fair value |  | $ 3,714,000 |  |
Sonex Health, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 8.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,714,000 |  |
Investments at fair value |  | $ 3,714,000 |  |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 11.25% |
Margin |  |  | 6.00% |
Floor |  |  | 9.50% |
Ceiling |  |  | 11.25% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jul. 01, 2027 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,608,000 |
Investments at fair value |  |  | 3,608,000 |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 94,000 |
Investments at fair value |  |  | $ 250,000 |
Number of Shares (in shares) |  |  | 37,282 |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 11.25% |
Margin |  |  | 6.00% |
Floor |  |  | 9.50% |
Ceiling |  |  | 11.25% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jul. 01, 2027 |
Principal Amount |  |  | $ 1,250,000 |
Investments at cost |  |  | 1,242,000 |
Investments at fair value |  |  | $ 1,242,000 |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 11.25% |
Margin |  |  | 6.00% |
Floor |  |  | 9.50% |
Ceiling |  |  | 11.25% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jul. 01, 2027 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,726,000 |
Investments at fair value |  |  | $ 3,726,000 |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 11.25% |
Margin |  |  | 6.00% |
Floor |  |  | 9.50% |
Ceiling |  |  | 11.25% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jul. 01, 2027 |
Principal Amount |  |  | $ 1,250,000 |
Investments at cost |  |  | 1,242,000 |
Investments at fair value |  |  | $ 1,242,000 |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  |  | 11.25% |
Margin |  |  | 6.00% |
Floor |  |  | 9.50% |
Ceiling |  |  | 11.25% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jul. 01, 2027 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,726,000 |
Investments at fair value |  |  | $ 3,726,000 |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  |  | 11.25% |
Margin |  |  | 6.00% |
Floor |  |  | 9.50% |
Ceiling |  |  | 11.25% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jul. 01, 2027 |
Principal Amount |  |  | $ 1,250,000 |
Investments at cost |  |  | 1,242,000 |
Investments at fair value |  |  | $ 1,242,000 |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate |  |  | 11.25% |
Margin |  |  | 6.00% |
Floor |  |  | 9.50% |
Ceiling |  |  | 11.25% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,712,000 |
Investments at fair value |  |  | $ 3,712,000 |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate |  |  | 11.25% |
Margin |  |  | 6.00% |
Floor |  |  | 9.50% |
Ceiling |  |  | 11.25% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jan. 01, 2028 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,712,000 |
Investments at fair value |  |  | $ 3,712,000 |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Nine [Member] |  |  |  |
Cash Rate |  |  | 11.25% |
Margin |  |  | 6.00% |
Floor |  |  | 9.50% |
Ceiling |  |  | 11.25% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Apr. 01, 2028 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,706,000 |
Investments at fair value |  |  | $ 3,706,000 |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Ten [Member] |  |  |  |
Cash Rate |  |  | 11.25% |
Margin |  |  | 6.00% |
Floor |  |  | 9.50% |
Ceiling |  |  | 11.25% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jul. 01, 2028 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,707,000 |
Investments at fair value |  |  | $ 3,707,000 |
Divergent Technologies, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Eleven [Member] |  |  |  |
Cash Rate |  |  | 11.25% |
Margin |  |  | 6.00% |
Floor |  |  | 9.50% |
Ceiling |  |  | 11.25% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Jul. 01, 2028 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,707,000 |
Investments at fair value |  |  | $ 3,707,000 |
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 15.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Apr. 01, 2028 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,694,000 |
Investments at fair value |  |  | 3,694,000 |
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 175,000 |
Investments at fair value |  |  | $ 80,000 |
Number of Shares (in shares) |  |  | 46,311 |
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 15.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Apr. 01, 2028 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,694,000 |
Investments at fair value |  |  | $ 3,694,000 |
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 15.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Apr. 01, 2028 |
Principal Amount |  |  | $ 7,500,000 |
Investments at cost |  |  | 7,379,000 |
Investments at fair value |  |  | $ 7,379,000 |
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 15.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Apr. 01, 2028 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,690,000 |
Investments at fair value |  |  | $ 3,690,000 |
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  |  | 15.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Apr. 01, 2028 |
Principal Amount |  |  | $ 3,750,000 |
Investments at cost |  |  | 3,690,000 |
Investments at fair value |  |  | $ 3,690,000 |
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 6.00% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.00% |
Maturity Date |  |  | Jan. 01, 2029 |
Principal Amount |  |  | $ 4,500,000 |
Investments at cost |  |  | 4,446,000 |
Investments at fair value |  |  | $ 4,446,000 |
Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 6.00% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.00% |
Maturity Date |  |  | Jan. 01, 2029 |
Principal Amount |  |  | $ 2,000,000 |
Investments at cost |  |  | 1,976,000 |
Investments at fair value |  |  | 1,976,000 |
SafelyYou, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 163,000 |
Investments at fair value |  |  | $ 50,000 |
Number of Shares (in shares) |  |  | 150,353 |
SafelyYou, Inc [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 11.75% |
Margin |  |  | 3.25% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jun. 01, 2027 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,648,000 |
Investments at fair value |  |  | $ 4,648,000 |
SafelyYou, Inc [Member] | Software, Healthcare Information and Service [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 11.75% |
Margin |  |  | 3.25% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jun. 01, 2027 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,918,000 |
Investments at fair value |  |  | 4,918,000 |
Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 64,000 |
Investments at fair value |  |  | $ 157,000 |
Number of Shares (in shares) |  |  | 103,679 |
Topia Mobility, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 138,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 3,049,607 |
InfoBionic, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 4.50% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.00% |  |
Maturity Date |  | Sep. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,920,000 |  |
Investments at fair value |  | $ 4,920,000 |  |
InfoBionic, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 124,000 |
Investments at fair value |  |  | $ 26,000 |
Number of Shares (in shares) |  |  | 2,010,424 |
InfoBionic, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 4.50% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.00% |  |
Maturity Date |  | Sep. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,920,000 |  |
Investments at fair value |  | $ 4,920,000 |  |
InfoBionic, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 4.50% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.00% |  |
Maturity Date |  | Sep. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,920,000 |  |
Investments at fair value |  | $ 4,920,000 |  |
PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 160,000 |
Investments at fair value |  |  | $ 606,000 |
Number of Shares (in shares) |  |  | 299,848 |
Spineology, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 12.50% | 15.50% |
Margin |  | 5.00% | 7.00% |
Floor |  | 12.00% | 10.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 1.00% | 1.00% |
Maturity Date |  | Aug. 01, 2029 | Oct. 01, 2025 |
Principal Amount |  | $ 5,000,000 | $ 5,000,000 |
Investments at cost |  | 4,916,000 | 4,978,000 |
Investments at fair value |  | $ 4,916,000 | $ 4,978,000 |
Spineology, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  | 12.50% | 15.50% |
Margin |  | 5.00% | 7.00% |
Floor |  | 12.00% | 10.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 1.00% | 1.00% |
Maturity Date |  | Aug. 01, 2029 | Apr. 01, 2026 |
Principal Amount |  | $ 4,250,000 | $ 2,500,000 |
Investments at cost |  | 4,178,000 | 2,489,000 |
Investments at fair value |  | $ 4,178,000 | $ 2,489,000 |
Spineology, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  | 12.50% |  |
Margin |  | 5.00% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 1.00% |  |
Maturity Date |  | Aug. 01, 2029 |  |
Principal Amount |  | $ 4,250,000 |  |
Investments at cost |  | 4,178,000 |  |
Investments at fair value |  | $ 4,178,000 |  |
Spineology, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  | 12.50% |  |
Margin |  | 5.00% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 1.00% |  |
Maturity Date |  | Aug. 01, 2029 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,458,000 |  |
Investments at fair value |  | 2,458,000 |  |
Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 15.00% |
Margin |  |  | 6.50% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Mar. 01, 2026 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,971,000 |
Investments at fair value |  |  | 4,971,000 |
Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 32,000 |
Investments at fair value |  |  | $ 120,000 |
Number of Shares (in shares) |  |  | 101,308 |
Lemongrass Holdings, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 15.00% |
Margin |  |  | 6.50% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Mar. 01, 2026 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,486,000 |
Investments at fair value |  |  | 2,486,000 |
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 312,000 |
Investments at fair value |  |  | $ 225,000 |
Number of Shares (in shares) |  |  | 691,895 |
Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 278,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 175,098 |
Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.50% |
Margin |  |  | 4.00% |
Floor |  |  | 11.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.50% |
Maturity Date |  |  | Jun. 01, 2027 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,773,000 |
Investments at fair value |  |  | 4,773,000 |
Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 120,000 |
Investments at fair value |  |  | $ 105,000 |
Number of Shares (in shares) |  |  | 345,443 |
Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 12.50% |
Margin |  |  | 4.00% |
Floor |  |  | 11.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.50% |
Maturity Date |  |  | Jun. 01, 2027 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,467,000 |
Investments at fair value |  |  | $ 2,467,000 |
Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 12.50% |
Margin |  |  | 4.00% |
Floor |  |  | 11.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.50% |
Maturity Date |  |  | Jun. 01, 2027 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,467,000 |
Investments at fair value |  |  | 2,467,000 |
Intelepeer Holdings, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 138,000 |
Investments at fair value |  |  | $ 3,036,000 |
Number of Shares (in shares) |  |  | 2,936,535 |
Lumithera, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Royalty Agreement [Member] |  |  |  |
Investments at cost |  |  | $ 1,200,000 |
Investments at fair value |  |  | 200,000 |
xAd, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 177,000 |
Investments at fair value |  |  | $ 5,000 |
Number of Shares (in shares) |  |  | 4,343,348 |
Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 6.00% |
Floor |  |  | 14.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Nov. 01, 2026 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,471,000 |
Investments at fair value |  |  | 2,373,000 |
Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 43,000 |
Investments at fair value |  |  | $ 1,000 |
Number of Shares (in shares) |  |  | 85,543 |
Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 6.00% |
Floor |  |  | 14.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Dec. 01, 2026 |
Principal Amount |  |  | $ 1,250,000 |
Investments at cost |  |  | 1,237,000 |
Investments at fair value |  |  | $ 1,188,000 |
Lytics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 14.50% |
Margin |  |  | 6.00% |
Floor |  |  | 14.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Apr. 01, 2027 |
Principal Amount |  |  | $ 1,000,000 |
Investments at cost |  |  | 994,000 |
Investments at fair value |  |  | 954,000 |
PebblePost, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 92,000 |
Investments at fair value |  |  | $ 131,000 |
Number of Shares (in shares) |  |  | 598,850 |
ZetrOZ, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Royalty Agreement [Member] |  |  |  |
Investments at cost |  |  | $ 0 |
Investments at fair value |  |  | $ 0 |
Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 4.25% |
Floor |  |  | 12.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Jun. 01, 2028 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,457,000 |
Investments at fair value |  |  | 2,457,000 |
Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 64,000 |
Investments at fair value |  |  | $ 135,000 |
Number of Shares (in shares) |  |  | 682 |
Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 4.25% |
Floor |  |  | 12.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Jun. 01, 2028 |
Principal Amount |  |  | $ 3,500,000 |
Investments at cost |  |  | 3,489,000 |
Investments at fair value |  |  | $ 3,489,000 |
Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 4.25% |
Floor |  |  | 12.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Jun. 01, 2028 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,492,000 |
Investments at fair value |  |  | $ 2,492,000 |
Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 4.25% |
Floor |  |  | 12.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 2.50% |
Maturity Date |  |  | Jun. 01, 2028 |
Principal Amount |  |  | $ 1,500,000 |
Investments at cost |  |  | 1,495,000 |
Investments at fair value |  |  | 1,495,000 |
Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 264,000 |
Investments at fair value |  |  | $ 113,000 |
Number of Shares (in shares) |  |  | 318,181 |
Alula Holdings, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 93,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 20,000 |
Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 194,000 |
Investments at fair value |  |  | $ 172,000 |
Number of Shares (in shares) |  |  | 1,600,002 |
Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 12.75% |
Margin |  |  | 4.25% |
Floor |  |  | 12.25% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Aug. 01, 2027 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,459,000 |
Investments at fair value |  |  | 2,459,000 |
Aterian, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 195,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 76,923 |
Cadrenal Therapeutics, Inc. [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at fair value | [1] |  | $ 0 | $ 0
Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Aug. 01, 2027 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,416,000 |
Investments at fair value |  |  | 2,416,000 |
Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 182,000 |
Investments at fair value |  |  | $ 145,000 |
Number of Shares (in shares) |  |  | 11,550 |
Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Jul. 01, 2028 |
Principal Amount |  |  | $ 1,875,000 |
Investments at cost |  |  | 1,787,000 |
Investments at fair value |  |  | 1,787,000 |
Xeris Pharmaceuticals, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 72,000 |
Investments at fair value |  |  | $ 33,000 |
Number of Shares (in shares) |  |  | 126,000 |
Caastle, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 65,000 |
Investments at fair value |  |  | $ 1,055,000 |
Number of Shares (in shares) |  |  | 268,591 |
AccuVein Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 24,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 1,175 |
Aerin Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 66,000 |
Investments at fair value |  |  | $ 1,199,000 |
Number of Shares (in shares) |  |  | 1,818,183 |
Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 48,000 |
Investments at fair value |  |  | $ 9,000 |
Number of Shares (in shares) |  |  | 8,800 |
Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Fixed Index One [Member] |  |  |  |
Cash Rate |  |  | 9.00% |
Margin |  |  | 0.00% |
Floor |  |  | 0.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 18.00% |
Maturity Date |  |  | Apr. 01, 2028 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,468,000 |
Investments at fair value |  |  | $ 2,342,000 |
Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Fixed Index Two [Member] |  |  |  |
Cash Rate |  |  | 9.00% |
Margin |  |  | 0.00% |
Floor |  |  | 0.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 18.00% |
Maturity Date |  |  | Apr. 01, 2028 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,468,000 |
Investments at fair value |  |  | $ 2,342,000 |
Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Fixed Index Three [Member] |  |  |  |
Cash Rate |  |  | 9.00% |
Margin |  |  | 0.00% |
Floor |  |  | 0.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 18.00% |
Maturity Date |  |  | Jun. 30, 2024 |
Principal Amount |  |  | $ 200,000 |
Investments at cost |  |  | 200,000 |
Investments at fair value |  |  | 190,000 |
CZV, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 81,000 |
Investments at fair value |  |  | $ 71,000 |
Number of Shares (in shares) |  |  | 65,569 |
Canary Medical Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 86,000 |
Investments at fair value |  |  | $ 1,305,000 |
Number of Shares (in shares) |  |  | 12,153 |
Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 16.25% |
Margin |  |  | 7.75% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 0.00% |
Maturity Date |  |  | May 01, 2027 |
Principal Amount |  |  | $ 1,204,000 |
Investments at cost |  |  | 1,086,000 |
Investments at fair value |  |  | 872,000 |
Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 32,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 171,081 |
Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 16.25% |
Margin |  |  | 7.75% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 0.00% |
Maturity Date |  |  | May 01, 2027 |
Principal Amount |  |  | $ 602,000 |
Investments at cost |  |  | 543,000 |
Investments at fair value |  |  | $ 436,000 |
Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 16.25% |
Margin |  |  | 7.75% |
Floor |  |  | 11.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 0.00% |
Maturity Date |  |  | May 01, 2027 |
Principal Amount |  |  | $ 602,000 |
Investments at cost |  |  | 543,000 |
Investments at fair value |  |  | $ 436,000 |
MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 15.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Oct. 01, 2025 |
Principal Amount |  |  | $ 3,667,000 |
Investments at cost |  |  | 3,647,000 |
Investments at fair value |  |  | 3,647,000 |
MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 29,000 |
Investments at fair value |  |  | $ 56,000 |
Number of Shares (in shares) |  |  | 250 |
MyForest Foods Co [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 15.25% |
Margin |  |  | 6.75% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Oct. 01, 2025 |
Principal Amount |  |  | $ 1,833,000 |
Investments at cost |  |  | 1,824,000 |
Investments at fair value |  |  | $ 1,824,000 |
Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 8.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 6.00% |
Maturity Date |  |  | Aug. 01, 2026 |
Principal Amount |  |  | $ 4,583,000 |
Investments at cost |  |  | 4,546,000 |
Investments at fair value |  |  | 4,546,000 |
Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 149,000 |
Investments at fair value |  |  | $ 167,000 |
Number of Shares (in shares) |  |  | 4,106,174 |
Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 8.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 6.00% |
Maturity Date |  |  | Aug. 01, 2026 |
Principal Amount |  |  | $ 2,292,000 |
Investments at cost |  |  | 2,273,000 |
Investments at fair value |  |  | $ 2,273,000 |
Reputation Institute, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 15.75% |
Margin |  |  | 7.25% |
Floor |  |  | 10.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Aug. 01, 2025 |
Principal Amount |  |  | $ 3,667,000 |
Investments at cost |  |  | 3,625,000 |
Investments at fair value |  |  | 3,625,000 |
Reputation Institute, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 56,000 |
Investments at fair value |  |  | $ 80,000 |
Number of Shares (in shares) |  |  | 3,731 |
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 13.59% |
Margin |  |  | 5.09% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jan. 01, 2024 |
Principal Amount |  |  | $ 500,000 |
Investments at cost |  |  | 500,000 |
Investments at fair value |  |  | 500,000 |
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 174,000 |
Investments at fair value |  |  | $ 124,000 |
Number of Shares (in shares) |  |  | 3,341,376 |
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 13.59% |
Margin |  |  | 5.09% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Jan. 01, 2024 |
Principal Amount |  |  | $ 33,000 |
Investments at cost |  |  | 33,000 |
Investments at fair value |  |  | $ 33,000 |
CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 13.59% |
Margin |  |  | 5.09% |
Floor |  |  | 10.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Mar. 01, 2024 |
Principal Amount |  |  | $ 800,000 |
Investments at cost |  |  | 794,000 |
Investments at fair value |  |  | 794,000 |
Lotame Solutions, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 18,000 |
Investments at fair value |  |  | $ 42,000 |
Number of Shares (in shares) |  |  | 71,305 |
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 14.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Oct. 01, 2028 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,860,000 |
Investments at fair value |  |  | 4,860,000 |
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 98,000 |
Investments at fair value |  |  | $ 174,000 |
Number of Shares (in shares) |  |  | 161,215 |
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 14.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Oct. 01, 2028 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,466,000 |
Investments at fair value |  |  | $ 2,466,000 |
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 14.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Oct. 01, 2028 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,466,000 |
Investments at fair value |  |  | $ 2,466,000 |
Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 14.00% |
Margin |  |  | 5.50% |
Floor |  |  | 14.00% |
Ceiling |  |  | 0.00% |
ETP |  |  | 3.00% |
Maturity Date |  |  | Oct. 01, 2028 |
Principal Amount |  |  | $ 2,500,000 |
Investments at cost |  |  | 2,466,000 |
Investments at fair value |  |  | 2,466,000 |
CVRx, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 76,000 |
Investments at fair value |  |  | $ 980,000 |
Number of Shares (in shares) |  |  | 47,410 |
Primary Kids, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 57,000 |
Investments at fair value |  |  | $ 591,000 |
Number of Shares (in shares) |  |  | 553,778 |
Quip NYC Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 325,000 |
Investments at fair value |  |  | $ 533,000 |
Number of Shares (in shares) |  |  | 6,191 |
Updater, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 34,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 114,659 |
CPG Beyond, Inc [Member] | Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 242,000 |
Investments at fair value |  |  | $ 294,000 |
Number of Shares (in shares) |  |  | 500,000 |
Silk, Inc [Member] | Data Storage Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 175,000 |
Investments at fair value |  |  | $ 124,000 |
Number of Shares (in shares) |  |  | 394,110 |
Global Worldwide LLC [Member] | Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 75,000 |
Investments at fair value |  |  | $ 63,000 |
Number of Shares (in shares) |  |  | 245,810 |
Rocket Lawyer Incorporated [Member] | Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 92,000 |
Investments at fair value |  |  | $ 318,000 |
Number of Shares (in shares) |  |  | 261,721 |
Skillshare, Inc [Member] | Internet and Media Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 162,000 |
Investments at fair value |  |  | $ 1,201,000 |
Number of Shares (in shares) |  |  | 139,074 |
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  |  | 14.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Sep. 01, 2024 |
Principal Amount |  |  | $ 1,500,000 |
Investments at cost |  |  | 1,481,000 |
Investments at fair value |  |  | 1,481,000 |
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 364,000 |
Investments at fair value |  |  | $ 210,000 |
Number of Shares (in shares) |  |  | 344,102 |
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Two [Member] |  |  |  |
Cash Rate |  |  | 14.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Sep. 01, 2024 |
Principal Amount |  |  | $ 1,500,000 |
Investments at cost |  |  | 1,481,000 |
Investments at fair value |  |  | $ 1,481,000 |
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index Three [Member] |  |  |  |
Cash Rate |  |  | 14.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Sep. 01, 2024 |
Principal Amount |  |  | $ 750,000 |
Investments at cost |  |  | 740,000 |
Investments at fair value |  |  | $ 740,000 |
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate |  |  | 14.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Sep. 01, 2024 |
Principal Amount |  |  | $ 667,000 |
Investments at cost |  |  | 656,000 |
Investments at fair value |  |  | $ 656,000 |
Liqid, Inc [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  |  | 14.75% |
Margin |  |  | 6.25% |
Floor |  |  | 9.50% |
Ceiling |  |  | 0.00% |
ETP |  |  | 4.00% |
Maturity Date |  |  | Sep. 01, 2024 |
Principal Amount |  |  | $ 750,000 |
Investments at cost |  |  | 729,000 |
Investments at fair value |  |  | 729,000 |
Halio, Inc [Member] | Power Management Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | 1,585,000 |
Investments at fair value |  |  | $ 2,700,000 |
Number of Shares (in shares) |  |  | 38,241,466 |
Avalanche Technology, Inc [Member] | Semiconductor Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 45,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 5,938 |
E La Carte, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 60,000 |
Investments at fair value |  |  | $ 0 |
Number of Shares (in shares) |  |  | 147,361 |
Everstream Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost |  |  | $ 70,000 |
Investments at fair value |  |  | $ 63,000 |
Number of Shares (in shares) |  |  | 350,000 |
Unrestricted Short Term Investments [Member] |  |  |  |
Investments at cost |  | 27,266,000 | $ 26,450,000 |
Investments at fair value |  | 27,266,000 | 26,450,000 |
Unrestricted Short Term Investments [Member] | U S Bank Money Market Deposit Account [Member] |  |  |  |
Investments at cost |  | 27,266,000 | 26,450,000 |
Investments at fair value |  | 27,266,000 | 26,450,000 |
Common Stock [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | 5,000,000 | 5,000,000 |
Investments at fair value |  | $ 0 | $ 132,000 |
Number of Shares (in shares) |  | 2,164,502 | 2,164,502 |
Common Stock [Member] | Aulea Medical, Inc. [Member] | Medical Device Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | $ 0 | $ 0 |
Investments at fair value |  | $ 0 | $ 0 |
Number of Shares (in shares) |  | 660,537 | 660,537 |
Common Stock [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  | $ 639,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 2,278,272 |  |
Common Stock [Member] | Better Place Forests Co. [Member] | Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  |  | $ 2,061,000 |
Investments at fair value |  |  | $ 2,165,000 |
Number of Shares (in shares) |  |  | 2,278,272 |
Common Stock [Member] | Castle Creek Biosciences, Inc [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 250,000 |  |
Investments at fair value |  | $ 250,000 |  |
Number of Shares (in shares) |  | 1,162 |  |
Common Stock [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | $ 250,000 |
Investments at fair value |  |  | $ 250,000 |
Number of Shares (in shares) |  |  | 1,162 |
Common Stock [Member] | Emalex Biosciences, Inc. [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 356,000 |  |
Investments at fair value |  | $ 356,000 |  |
Number of Shares (in shares) |  | 32,831 |  |
Common Stock [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | $ 355,000 |
Investments at fair value |  |  | $ 355,000 |
Number of Shares (in shares) |  |  | 32,831 |
Common Stock [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  | $ 3,297,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 108,320 |  |
Common Stock [Member] | Lumithera, Inc. [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 2,000,000 |  |
Investments at fair value |  | $ 1,700,000 |  |
Number of Shares (in shares) |  | 392,651 |  |
Common Stock [Member] | Lumithera, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | $ 2,000,000 |
Investments at fair value |  |  | $ 1,700,000 |
Number of Shares (in shares) |  |  | 392,651 |
Common Stock [Member] | Cadrenal Therapeutics, Inc. [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 0 |  |
Investments at fair value |  | $ 580,000 |  |
Number of Shares (in shares) |  | 40,000 |  |
Common Stock [Member] | Cadrenal Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | $ 0 |
Investments at fair value |  |  | $ 443,000 |
Number of Shares (in shares) |  |  | 600,000 |
Common Stock [Member] | Getaround, Inc [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 253,000 |  |
Investments at fair value |  | $ 3,000 |  |
Number of Shares (in shares) |  | 87,082 |  |
Common Stock [Member] | Getaround, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | $ 253,000 |
Investments at fair value |  |  | $ 20,000 |
Number of Shares (in shares) |  |  | 87,082 |
Common Stock [Member] | SnagAJob.com, Inc [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 9,000 |  |
Investments at fair value |  | $ 83,000 |  |
Number of Shares (in shares) |  | 82,974 |  |
Common Stock [Member] | SnagAJob.com, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | $ 9,000 |
Investments at fair value |  |  | $ 83,000 |
Number of Shares (in shares) |  |  | 82,974 |
Common Stock [Member] | Cognoa, Inc. [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 487,000 |  |
Investments at fair value |  | $ 487,000 |  |
Number of Shares (in shares) |  | 8,123,877 |  |
Common Stock [Member] | Tigo Energy, Inc. [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 111,000 |  |
Investments at fair value |  | $ 5,000 |  |
Number of Shares (in shares) |  | 5,205 |  |
Common Stock [Member] | Tigo Energy, Inc. [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | $ 111,000 |
Investments at fair value |  |  | $ 13,000 |
Number of Shares (in shares) |  |  | 5,205 |
Term Loan, Prime Index, One [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 6.50% |  |
Floor |  | 9.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jun. 01, 2026 |  |
Principal Amount |  | $ 6,804,000 |  |
Investments at cost |  | 6,740,000 |  |
Investments at fair value |  | $ 6,362,000 |  |
Term Loan, Prime Index, One [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 6.00% |  |
Floor |  | 9.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jun. 01, 2026 |  |
Principal Amount |  | $ 1,607,000 |  |
Investments at cost |  | 1,576,000 |  |
Investments at fair value |  | $ 943,000 |  |
Term Loan, Prime Index, One [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.75% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.78% |  |
Maturity Date |  | Aug. 01, 2029 |  |
Principal Amount |  | $ 4,012,000 |  |
Investments at cost |  | 4,058,000 |  |
Investments at fair value |  | $ 0 |  |
Term Loan, Prime Index, One [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.88% | 13.25% |
Margin |  | 5.13% | 4.75% |
Floor |  | 9.55% | 9.55% |
Ceiling |  | 13.50% | 13.50% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 3,333,000 | $ 5,000,000 |
Investments at cost |  | 3,326,000 | 4,979,000 |
Investments at fair value |  | $ 3,326,000 | $ 4,979,000 |
Term Loan, Prime Index, One [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.50% |  |
Margin |  | 3.50% |  |
Floor |  | 11.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Sep. 01, 2027 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,785,000 |  |
Investments at fair value |  | $ 4,785,000 |  |
Term Loan, Prime Index, One [Member] | VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 3.75% |  |
Floor |  | 12.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 15,000,000 |  |
Investments at cost |  | 14,735,000 |  |
Investments at fair value |  | $ 14,735,000 |  |
Term Loan, Prime Index, One [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.50% |  |
Margin |  | 5.00% |  |
Floor |  | 5.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 10.40% |  |
Maturity Date |  | Mar. 01, 2027 |  |
Principal Amount |  | $ 2,000,000 |  |
Investments at cost |  | 1,568,000 |  |
Investments at fair value |  | $ 1,568,000 |  |
Term Loan, Prime Index, One [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.00% |  |
Margin |  | 5.50% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Apr. 01, 2026 |  |
Principal Amount |  | $ 10,000,000 |  |
Investments at cost |  | 9,977,000 |  |
Investments at fair value |  | $ 9,977,000 |  |
Term Loan, Prime Index, One [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.25% |  |
Margin |  | 5.50% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Aug. 01, 2027 |  |
Principal Amount |  | $ 7,000,000 |  |
Investments at cost |  | 6,954,000 |  |
Investments at fair value |  | $ 6,954,000 |  |
Term Loan, Prime Index, One [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.75% |  |
Margin |  | 6.00% |  |
Floor |  | 9.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Jun. 01, 2026 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,731,000 |  |
Investments at fair value |  | $ 3,731,000 |  |
Term Loan, Prime Index, One [Member] | Parse Biosciences, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.50% |  |
Margin |  | 3.25% |  |
Floor |  | 11.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jan. 01, 2028 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,659,000 |  |
Investments at fair value |  | $ 4,659,000 |  |
Term Loan, Prime Index, One [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.50% |  |
Margin |  | 5.00% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Mar. 01, 2027 |  |
Principal Amount |  | $ 10,000,000 |  |
Investments at cost |  | 9,928,000 |  |
Investments at fair value |  | $ 9,928,000 |  |
Term Loan, Prime Index, One [Member] | OneNetworks, Inc. dba Finexio [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.125% |  |
Margin |  | 3.625% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.75% |  |
Maturity Date |  | Jan. 01, 2030 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,448,000 |  |
Investments at fair value |  | $ 2,448,000 |  |
Term Loan, Prime Index, One [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.22% | 13.22% |
Margin |  | 4.72% | 4.72% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Nov. 01, 2025 | Jun. 01, 2024 |
Principal Amount |  | $ 4,167,000 | $ 1,414,000 |
Investments at cost |  | 4,144,000 | 1,410,000 |
Investments at fair value |  | $ 4,144,000 | $ 1,410,000 |
Term Loan, Prime Index, One [Member] | Lyrical Foods, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.00% |  |
Margin |  | 3.50% |  |
Floor |  | 9.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jul. 01, 2028 |  |
Principal Amount |  | $ 2,679,000 |  |
Investments at cost |  | 2,768,000 |  |
Investments at fair value |  | $ 2,405,000 |  |
Term Loan, Prime Index, One [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,934,000 |  |
Investments at fair value |  | $ 4,934,000 |  |
Term Loan, Prime Index, One [Member] | Elligo Healthcare Research, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2027 |  |
Principal Amount |  | $ 10,000,000 |  |
Investments at cost |  | 9,890,000 |  |
Investments at fair value |  | $ 9,890,000 |  |
Term Loan, Prime Index, One [Member] | Pivot Bio, Inc. [Member] | Energy Efficiency [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 4.00% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Feb. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,742,000 |  |
Investments at fair value |  | $ 4,742,000 |  |
Term Loan, Prime Index, One [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 5.75% |  |
Floor |  | 9.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.25% |  |
Maturity Date |  | Oct. 31, 2023 |  |
Principal Amount |  | $ 6,042,000 |  |
Investments at cost |  | 5,415,000 |  |
Investments at fair value |  | $ 1,271,000 |  |
Term Loan, Prime Index, One [Member] | KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.25% | 13.25% |
Margin |  | 4.75% | 4.75% |
Floor |  | 8.50% | 8.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2027 | May 01, 2027 |
Principal Amount |  | $ 6,250,000 | $ 6,250,000 |
Investments at cost |  | 6,220,000 | 6,199,000 |
Investments at fair value |  | $ 6,220,000 | $ 6,199,000 |
Term Loan, Prime Index, One [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 10.25% |  |
Margin |  | 2.50% |  |
Floor |  | 2.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 9.14% |  |
Maturity Date |  | Jun. 01, 2028 |  |
Principal Amount |  | $ 1,948,000 |  |
Investments at cost |  | 1,925,000 |  |
Investments at fair value |  | $ 1,658,000 |  |
Term Loan, Prime Index, One [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.75% |  |
Maturity Date |  | Apr. 01, 2026 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,922,000 |  |
Investments at fair value |  | $ 4,792,000 |  |
Term Loan, Prime Index, One [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,707,000 |  |
Investments at fair value |  | $ 3,707,000 |  |
Term Loan, Prime Index, One [Member] | SafelyYou, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.00% |  |
Margin |  | 3.25% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jun. 01, 2027 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,872,000 |  |
Investments at fair value |  | $ 4,872,000 |  |
Term Loan, Prime Index, One [Member] | Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.33% |  |
Maturity Date |  | Dec. 01, 2026 |  |
Principal Amount |  | $ 3,594,000 |  |
Investments at cost |  | 3,564,000 |  |
Investments at fair value |  | $ 3,564,000 |  |
Term Loan, Prime Index, One [Member] | Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.75% | 13.75% |
Margin |  | 5.25% | 5.25% |
Floor |  | 8.50% | 8.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Nov. 01, 2026 | Nov. 01, 2026 |
Principal Amount |  | $ 2,875,000 | $ 3,750,000 |
Investments at cost |  | 2,862,000 | 3,716,000 |
Investments at fair value |  | $ 2,862,000 | $ 3,716,000 |
Term Loan, Prime Index, One [Member] | Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.25% | 14.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Jul. 01, 2025 | Jul. 01, 2025 |
Principal Amount |  | $ 1,000,000 | $ 3,000,000 |
Investments at cost |  | 971,000 | 2,914,000 |
Investments at fair value |  | $ 971,000 | $ 2,870,000 |
Term Loan, Prime Index, One [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.25% | 14.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.75% | 3.75% |
Maturity Date |  | Sep. 01, 2026 | Sep. 01, 2026 |
Principal Amount |  | $ 8,750,000 | $ 10,000,000 |
Investments at cost |  | 8,712,000 | 9,911,000 |
Investments at fair value |  | $ 8,712,000 | $ 9,911,000 |
Term Loan, Prime Index, One [Member] | Ursa Space Systems Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 4.00% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Nov. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,365,000 |  |
Investments at fair value |  | $ 2,365,000 |  |
Term Loan, Prime Index, One [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.86% | 13.86% |
Margin |  | 5.36% | 5.36% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.30% | 5.50% |
Maturity Date |  | Jan. 01, 2027 | Dec. 01, 2024 |
Principal Amount |  | $ 3,482,000 | $ 4,666,000 |
Investments at cost |  | 3,418,000 | 4,579,000 |
Investments at fair value |  | $ 3,182,000 | $ 4,414,000 |
Term Loan, Prime Index, One [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 4.00% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jun. 01, 2027 |  |
Principal Amount |  | $ 4,833,000 |  |
Investments at cost |  | 4,791,000 |  |
Investments at fair value |  | $ 4,791,000 |  |
Term Loan, Prime Index, One [Member] | GT Medical Technologies, Inc. [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.25% |  |
Margin |  | 3.25% |  |
Floor |  | 11.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2029 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,595,000 |  |
Investments at fair value |  | $ 3,595,000 |  |
Term Loan, Prime Index, One [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 4.25% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Jun. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,414,000 |  |
Investments at fair value |  | $ 2,414,000 |  |
Term Loan, Prime Index, One [Member] | Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.00% | 14.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 8.75% | 8.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 6.00% | 6.00% |
Maturity Date |  | Oct. 01, 2025 | Oct. 01, 2025 |
Principal Amount |  | $ 2,024,000 | $ 4,250,000 |
Investments at cost |  | 1,999,000 | 4,193,000 |
Investments at fair value |  | $ 1,999,000 | $ 4,193,000 |
Term Loan, Prime Index, One [Member] | Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.25% | 12.75% |
Margin |  | 4.25% | 4.25% |
Floor |  | 12.25% | 12.25% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.00% | 4.00% |
Maturity Date |  | Aug. 01, 2027 | Aug. 01, 2027 |
Principal Amount |  | $ 2,500,000 | $ 2,500,000 |
Investments at cost |  | 2,471,000 | 2,230,000 |
Investments at fair value |  | $ 2,471,000 | 2,230,000 |
Term Loan, Prime Index, One [Member] | Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 6.25% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Aug. 01, 2027 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,448,000 |  |
Investments at fair value |  | $ 2,448,000 |  |
Term Loan, Prime Index, One [Member] | Hometeam Technologies, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.25% |  |
Margin |  | 3.25% |  |
Floor |  | 11.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Aug. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,854,000 |  |
Investments at fair value |  | $ 4,854,000 |  |
Term Loan, Prime Index, One [Member] | Standvast Holdings, LLC [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.75% |  |
Margin |  | 4.25% |  |
Floor |  | 12.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Jun. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,339,000 |  |
Investments at fair value |  | $ 2,267,000 |  |
Term Loan, Prime Index, One [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 15.25% |  |
Margin |  | 7.75% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | May 01, 2027 |  |
Principal Amount |  | $ 1,415,000 |  |
Investments at cost |  | 1,086,000 |  |
Investments at fair value |  | $ 0 |  |
Term Loan, Prime Index, One [Member] | Fictiv, Inc. [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 10.88% |  |
Margin |  | 3.375% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Apr. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,706,000 |  |
Investments at fair value |  | $ 4,706,000 |  |
Term Loan, Prime Index, One [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 5.50% |  |
Floor |  | 14.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,909,000 |  |
Investments at fair value |  | $ 4,909,000 |  |
Term Loan, Prime Index, One [Member] | Crafty Holdings, Inc.[Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 4.50% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,846,000 |  |
Investments at fair value |  | 4,846,000 |  |
Other Investments, Prime Index, One [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | 4,910,000 |  |
Investments at fair value |  | 1,825 |  |
Preferred Stock [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  | 3,922,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 5,350,142 |  |
Preferred Stock [Member] | Better Place Forests Co. [Member] | Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  |  | 1,250,000 |
Investments at fair value |  |  | $ 859,000 |
Number of Shares (in shares) |  |  | 3,124,448 |
Preferred Stock [Member] | Axiom Space, Inc [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 261,000 |  |
Investments at fair value |  | $ 306,000 |  |
Number of Shares (in shares) |  | 1,810 |  |
Preferred Stock [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | $ 261,000 |
Investments at fair value |  |  | $ 306,000 |
Number of Shares (in shares) |  |  | 1,810 |
Preferred Stock [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  | $ 3,419,000 |  |
Investments at fair value |  | $ 7,909,000 |  |
Number of Shares (in shares) |  | 542 |  |
Preferred Stock [Member] | NextCar Holding Company, Inc [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 89,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 2,688,971 |  |
Preferred Stock [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | $ 89,000 |
Investments at fair value |  |  | $ 89,000 |
Number of Shares (in shares) |  |  | 2,688,971 |
Preferred Stock [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  | $ 10,012 |  |
Investments at fair value |  | $ 10,012 |  |
Number of Shares (in shares) |  | 3,588,505 |  |
Preferred Stock [Member] | PebblePost, Inc [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 73,000 |  |
Investments at fair value |  | $ 73,000 |  |
Number of Shares (in shares) |  | 56,212 |  |
Preferred Stock [Member] | Caastle, Inc [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 2,681,000 |  |
Investments at fair value |  | $ 2,681,000 |  |
Number of Shares (in shares) |  | 242,180 |  |
Preferred Stock [Member] | Cognoa, Inc. [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 250,000 |  |
Investments at fair value |  | $ 250,000 |  |
Number of Shares (in shares) |  | 1,059,636 |  |
Preferred Stock [Member] | Decisyon, Inc [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 2,800,000 |  |
Investments at fair value |  | $ 1,281,000 |  |
Number of Shares (in shares) |  | 280,000 |  |
Preferred Stock [Member] | Decisyon, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | $ 2,800,000 |
Investments at fair value |  |  | $ 1,281,000 |
Number of Shares (in shares) |  |  | 280,000 |
Preferred Stock [Member] | Lotame Solutions, Inc. [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 4,000 |  |
Investments at fair value |  | $ 193,000 |  |
Number of Shares (in shares) |  | 66,127 |  |
Preferred Stock [Member] | Lotame Solutions, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | $ 4,000 |
Investments at fair value |  |  | $ 193,000 |
Number of Shares (in shares) |  |  | 66,127 |
Term Loan, Prime Index Two [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 6.50% |  |
Floor |  | 9.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jun. 01, 2026 |  |
Principal Amount |  | $ 6,280,000 |  |
Investments at cost |  | 6,221,000 |  |
Investments at fair value |  | $ 5,872,000 |  |
Term Loan, Prime Index Two [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 6.00% |  |
Floor |  | 9.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jun. 01, 2026 |  |
Principal Amount |  | $ 1,607,000 |  |
Investments at cost |  | 1,576,000 |  |
Investments at fair value |  | $ 943,000 |  |
Term Loan, Prime Index Two [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.75% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.78% |  |
Maturity Date |  | Aug. 01, 2029 |  |
Principal Amount |  | $ 2,006,000 |  |
Investments at cost |  | 1,989,000 |  |
Investments at fair value |  | $ 0 |  |
Term Loan, Prime Index Two [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.88% | 13.25% |
Margin |  | 5.13% | 4.75% |
Floor |  | 9.55% | 9.55% |
Ceiling |  | 13.50% | 13.50% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 3,333,000 | $ 5,000,000 |
Investments at cost |  | 3,326,000 | 4,979,000 |
Investments at fair value |  | $ 3,326,000 | $ 4,979,000 |
Term Loan, Prime Index Two [Member] | VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 3.75% |  |
Floor |  | 12.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 10,000,000 |  |
Investments at cost |  | 9,823,000 |  |
Investments at fair value |  | $ 9,823,000 |  |
Term Loan, Prime Index Two [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.50% |  |
Margin |  | 5.00% |  |
Floor |  | 5.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 10.40% |  |
Maturity Date |  | Mar. 01, 2027 |  |
Principal Amount |  | $ 3,000,000 |  |
Investments at cost |  | 2,529,000 |  |
Investments at fair value |  | $ 2,529,000 |  |
Term Loan, Prime Index Two [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.00% |  |
Margin |  | 5.50% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Apr. 01, 2026 |  |
Principal Amount |  | $ 10,000,000 |  |
Investments at cost |  | 9,955,000 |  |
Investments at fair value |  | $ 9,955,000 |  |
Term Loan, Prime Index Two [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.25% |  |
Margin |  | 5.50% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Aug. 01, 2027 |  |
Principal Amount |  | $ 3,500,000 |  |
Investments at cost |  | 3,477,000 |  |
Investments at fair value |  | $ 3,477,000 |  |
Term Loan, Prime Index Two [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.75% |  |
Margin |  | 6.00% |  |
Floor |  | 9.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Jun. 01, 2026 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,731,000 |  |
Investments at fair value |  | $ 3,731,000 |  |
Term Loan, Prime Index Two [Member] | Parse Biosciences, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.50% |  |
Margin |  | 3.25% |  |
Floor |  | 11.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jan. 01, 2028 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,910,000 |  |
Investments at fair value |  | $ 4,910,000 |  |
Term Loan, Prime Index Two [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.50% |  |
Margin |  | 5.00% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Mar. 01, 2027 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,964,000 |  |
Investments at fair value |  | $ 4,964,000 |  |
Term Loan, Prime Index Two [Member] | OneNetworks, Inc. dba Finexio [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.125% |  |
Margin |  | 3.625% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.75% |  |
Maturity Date |  | Jan. 01, 2030 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,474,000 |  |
Investments at fair value |  | $ 2,474,000 |  |
Term Loan, Prime Index Two [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.22% | 13.22% |
Margin |  | 4.72% | 4.72% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | May 01, 2026 | Jun. 01, 2024 |
Principal Amount |  | $ 5,000,000 | $ 1,414,000 |
Investments at cost |  | 4,982,000 | 1,410,000 |
Investments at fair value |  | $ 4,982,000 | $ 1,410,000 |
Term Loan, Prime Index Two [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,934,000 |  |
Investments at fair value |  | $ 4,934,000 |  |
Term Loan, Prime Index Two [Member] | Elligo Healthcare Research, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2027 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,945,000 |  |
Investments at fair value |  | $ 4,945,000 |  |
Term Loan, Prime Index Two [Member] | Pivot Bio, Inc. [Member] | Energy Efficiency [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 4.00% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Feb. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,951,000 |  |
Investments at fair value |  | $ 4,951,000 |  |
Term Loan, Prime Index Two [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 5.75% |  |
Floor |  | 9.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.25% |  |
Maturity Date |  | Oct. 31, 2023 |  |
Principal Amount |  | $ 3,021,000 |  |
Investments at cost |  | 2,707,000 |  |
Investments at fair value |  | $ 635,000 |  |
Term Loan, Prime Index Two [Member] | KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.25% | 13.25% |
Margin |  | 4.75% | 4.75% |
Floor |  | 8.50% | 8.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2027 | May 01, 2027 |
Principal Amount |  | $ 6,250,000 | $ 6,250,000 |
Investments at cost |  | 6,220,000 | 6,199,000 |
Investments at fair value |  | $ 6,220,000 | $ 6,199,000 |
Term Loan, Prime Index Two [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 10.25% |  |
Margin |  | 2.50% |  |
Floor |  | 2.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 9.14% |  |
Maturity Date |  | Jun. 01, 2028 |  |
Principal Amount |  | $ 1,948,000 |  |
Investments at cost |  | 1,925,000 |  |
Investments at fair value |  | $ 1,658,000 |  |
Term Loan, Prime Index Two [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.75% |  |
Maturity Date |  | Apr. 01, 2026 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,461,000 |  |
Investments at fair value |  | $ 2,396,000 |  |
Term Loan, Prime Index Two [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,707,000 |  |
Investments at fair value |  | $ 3,707,000 |  |
Term Loan, Prime Index Two [Member] | SafelyYou, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.00% |  |
Margin |  | 3.25% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Jun. 01, 2027 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,945,000 |  |
Investments at fair value |  | $ 4,945,000 |  |
Term Loan, Prime Index Two [Member] | Aerofarms, Inc. [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.33% |  |
Maturity Date |  | Dec. 01, 2026 |  |
Principal Amount |  | $ 3,594,000 |  |
Investments at cost |  | 3,564,000 |  |
Investments at fair value |  | $ 3,564,000 |  |
Term Loan, Prime Index Two [Member] | Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.75% | 13.75% |
Margin |  | 5.25% | 5.25% |
Floor |  | 8.50% | 8.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 5.00% | 5.00% |
Maturity Date |  | Nov. 01, 2026 | Nov. 01, 2026 |
Principal Amount |  | $ 1,917,000 | $ 2,500,000 |
Investments at cost |  | 1,906,000 | 2,478,000 |
Investments at fair value |  | $ 1,906,000 | $ 2,478,000 |
Term Loan, Prime Index Two [Member] | Greenlight Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.25% | 14.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.00% | 9.00% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.00% | 3.00% |
Maturity Date |  | Jul. 01, 2025 | Jul. 01, 2025 |
Principal Amount |  | $ 500,000 | $ 1,500,000 |
Investments at cost |  | 486,000 | 1,458,000 |
Investments at fair value |  | $ 486,000 | $ 1,436,000 |
Term Loan, Prime Index Two [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.25% | 14.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.75% | 3.75% |
Maturity Date |  | Sep. 01, 2026 | Sep. 01, 2026 |
Principal Amount |  | $ 3,281,000 | $ 3,750,000 |
Investments at cost |  | 3,267,000 | 3,717,000 |
Investments at fair value |  | $ 3,267,000 | $ 3,717,000 |
Term Loan, Prime Index Two [Member] | Ursa Space Systems Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 4.00% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Nov. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,440,000 |  |
Investments at fair value |  | $ 2,440,000 |  |
Term Loan, Prime Index Two [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.86% | 13.86% |
Margin |  | 5.36% | 5.36% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.30% | 5.50% |
Maturity Date |  | Jan. 01, 2027 | Dec. 01, 2024 |
Principal Amount |  | $ 3,482,000 | $ 4,666,000 |
Investments at cost |  | 3,418,000 | 4,579,000 |
Investments at fair value |  | $ 3,182,000 | $ 4,414,000 |
Term Loan, Prime Index Two [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 4.00% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jun. 01, 2027 |  |
Principal Amount |  | $ 2,417,000 |  |
Investments at cost |  | 2,396,000 |  |
Investments at fair value |  | $ 2,396,000 |  |
Term Loan, Prime Index Two [Member] | GT Medical Technologies, Inc. [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.25% |  |
Margin |  | 3.25% |  |
Floor |  | 11.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2029 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,695,000 |  |
Investments at fair value |  | $ 3,695,000 |  |
Term Loan, Prime Index Two [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 4.25% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Jun. 01, 2028 |  |
Principal Amount |  | $ 3,500,000 |  |
Investments at cost |  | 3,492,000 |  |
Investments at fair value |  | $ 3,492,000 |  |
Term Loan, Prime Index Two [Member] | Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.00% | 14.00% |
Margin |  | 5.50% | 5.50% |
Floor |  | 8.75% | 8.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 6.00% | 6.00% |
Maturity Date |  | Oct. 01, 2025 | Oct. 01, 2025 |
Principal Amount |  | $ 1,012,000 |  |
Investments at cost |  | 1,000,000 | 2,096,000 |
Investments at fair value |  | $ 1,000,000 | 2,096,000 |
Term Loan, Prime Index Two [Member] | Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 4.25% |  |
Floor |  | 12.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Aug. 01, 2027 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,471,000 |  |
Investments at fair value |  | $ 2,471,000 |  |
Term Loan, Prime Index Two [Member] | Optoro, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 6.25% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jul. 01, 2028 |  |
Principal Amount |  | $ 1,875,000 |  |
Investments at cost |  | 1,805,000 |  |
Investments at fair value |  | $ 1,805,000 |  |
Term Loan, Prime Index Two [Member] | Hometeam Technologies, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.25% |  |
Margin |  | 3.25% |  |
Floor |  | 11.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Aug. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,954,000 |  |
Investments at fair value |  | $ 4,954,000 |  |
Term Loan, Prime Index Two [Member] | Standvast Holdings, LLC [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.75% |  |
Margin |  | 4.25% |  |
Floor |  | 12.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Jun. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,426,000 |  |
Investments at fair value |  | $ 2,352,000 |  |
Term Loan, Prime Index Two [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 15.25% |  |
Margin |  | 7.75% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | May 01, 2027 |  |
Principal Amount |  | $ 708,000 |  |
Investments at cost |  | 543,000 |  |
Investments at fair value |  | $ 0 |  |
Term Loan, Prime Index Two [Member] | Fictiv, Inc. [Member] | Networking Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 10.88% |  |
Margin |  | 3.375% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Apr. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,941,000 |  |
Investments at fair value |  | $ 4,941,000 |  |
Term Loan, Prime Index Two [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 5.50% |  |
Floor |  | 14.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,472,000 |  |
Investments at fair value |  | $ 2,472,000 |  |
Term Loan, Prime Index Two [Member] | Crafty Holdings, Inc.[Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 4.50% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,911,000 |  |
Investments at fair value |  | 4,911,000 |  |
Common Stock Warrants [Member] | DropOff, Inc. [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 455,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 516,535 |  |
Common Stock Warrants [Member] | Havenly, Inc. [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 3,178,000 |  |
Investments at fair value |  | $ 3,106,000 |  |
Number of Shares (in shares) |  | 1,446,429 |  |
Common Stock Warrants [Member] | Axiom Space, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 46,000 |  |
Investments at fair value |  | $ 35,000 |  |
Number of Shares (in shares) |  | 1,991 |  |
Common Stock Warrants [Member] | Parse Biosciences, Inc. [Member] | Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 71,000 |  |
Investments at fair value |  | $ 15,000 |  |
Number of Shares (in shares) |  | 32,244 |  |
Common Stock Warrants [Member] | Avalo Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 311,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 117 |  |
Common Stock Warrants [Member] | Mirantis, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 223,000 |  |
Investments at fair value |  | $ 585,000 |  |
Number of Shares (in shares) |  | 948,275 |  |
Common Stock Warrants [Member] | Imunon, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 65,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 19,671 |  |
Common Stock Warrants [Member] | NextCar Holding Company, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 188,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 12,618 |  |
Common Stock Warrants [Member] | Soli Organic, Inc [Member] | Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 20,000 |  |
Investments at fair value |  | $ 19,000 |  |
Number of Shares (in shares) |  | 296 |  |
Common Stock Warrants [Member] | Mustang Bio, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 146,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 16,611 |  |
Common Stock Warrants [Member] | Divergent Technologies, Inc. [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 79,000 |  |
Investments at fair value |  | $ 7,000 |  |
Number of Shares (in shares) |  | 9,801 |  |
Common Stock Warrants [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 160,000 |  |
Investments at fair value |  | $ 14,000 |  |
Number of Shares (in shares) |  | 299,848 |  |
Common Stock Warrants [Member] | Spineology, Inc [Member] | Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 143,000 |  |
Investments at fair value |  | $ 108,000 |  |
Number of Shares (in shares) |  | 2,714,033 |  |
Common Stock Warrants [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 278,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 175,098 |  |
Common Stock Warrants [Member] | Stealth BioTherapeutics Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 264,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 318,181 |  |
Common Stock Warrants [Member] | Xeris Pharmaceuticals, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 73,000 |  |
Investments at fair value |  | $ 91,000 |  |
Number of Shares (in shares) |  | 126,000 |  |
Common Stock Warrants [Member] | AccuVein Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 7,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 271 |  |
Common Stock Warrants [Member] | Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 0 |  |
Investments at fair value |  | $ 2,000 |  |
Number of Shares (in shares) |  | 30,585 |  |
Common Stock Warrants [Member] | Fictiv, Inc. [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 59,000 |  |
Investments at fair value |  | $ 77,000 |  |
Number of Shares (in shares) |  | 126,841 |  |
Common Stock Warrants [Member] | CVRx, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 76,000 |  |
Investments at fair value |  | $ 160,000 |  |
Number of Shares (in shares) |  | 47,410 |  |
Common Stock Warrants [Member] | Crafty Holdings, Inc.[Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 132,000 |  |
Investments at fair value |  | $ 132,000 |  |
Number of Shares (in shares) |  | 243,278 |  |
Common Stock Warrants [Member] | E La Carte, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 60,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 147,361 |  |
Preferred Stock Warrants [Member] | Hound Labs, Inc. [Member] | Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 45,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 451,796 |  |
Preferred Stock Warrants [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 214,000 |  |
Investments at fair value |  | $ 270,000 |  |
Number of Shares (in shares) |  | 7,404 |  |
Preferred Stock Warrants [Member] | Candesant Biomedical, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 152,000 |  |
Investments at fair value |  | $ 78,000 |  |
Number of Shares (in shares) |  | 93,336 |  |
Preferred Stock Warrants [Member] | VERO Biotech LLC [Member] | Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 376,000 |  |
Investments at fair value |  | $ 198,000 |  |
Number of Shares (in shares) |  | 3,701 |  |
Preferred Stock Warrants [Member] | Kodiak Robotics, Inc. [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 273,000 |  |
Investments at fair value |  | $ 15,000 |  |
Number of Shares (in shares) |  | 639,918 |  |
Preferred Stock Warrants [Member] | BrightInsight, Inc. [Member] | Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 167,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 85,066 |  |
Preferred Stock Warrants [Member] | Parse Biosciences, Inc. [Member] | Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 166,000 |  |
Investments at fair value |  | $ 15,000 |  |
Number of Shares (in shares) |  | 184,253 |  |
Preferred Stock Warrants [Member] | Magnolia Medical Technologies, Inc [Member] | Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 194,000 |  |
Investments at fair value |  | $ 368,000 |  |
Number of Shares (in shares) |  | 809,931 |  |
Preferred Stock Warrants [Member] | Noodle Partners, Inc. [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 116,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 84,037 |  |
Preferred Stock Warrants [Member] | Meditrina, Inc [Member] | Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 83,000 |  |
Investments at fair value |  | $ 34,000 |  |
Number of Shares (in shares) |  | 233,993 |  |
Preferred Stock Warrants [Member] | OneNetworks, Inc. dba Finexio [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 3,000 |  |
Investments at fair value |  | $ 3,000 |  |
Number of Shares (in shares) |  | 184,646 |  |
Preferred Stock Warrants [Member] | Scientia Vascular, Inc. [Member] | Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 103,000 |  |
Investments at fair value |  | $ 262,000 |  |
Number of Shares (in shares) |  | 34,410 |  |
Preferred Stock Warrants [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 82,000 |  |
Investments at fair value |  | $ 17,000 |  |
Number of Shares (in shares) |  | 400,000 |  |
Preferred Stock Warrants [Member] | Kate Farms, Inc [Member] | Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 101,000 |  |
Investments at fair value |  | $ 700,000 |  |
Number of Shares (in shares) |  | 82,965 |  |
Preferred Stock Warrants [Member] | Ceribell, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 147,000 |  |
Investments at fair value |  | $ 1,573,000 |  |
Number of Shares (in shares) |  | 89,903 |  |
Preferred Stock Warrants [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 176,000 |  |
Investments at fair value |  | $ 129,000 |  |
Number of Shares (in shares) |  | 110,402 |  |
Preferred Stock Warrants [Member] | MicroTransponder, Inc. [Member] | Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 47,000 |  |
Investments at fair value |  | $ 66,000 |  |
Number of Shares (in shares) |  | 103,172 |  |
Preferred Stock Warrants [Member] | Revinate Holdings, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 44,000 |  |
Investments at fair value |  | $ 90,000 |  |
Number of Shares (in shares) |  | 682,034 |  |
Preferred Stock Warrants [Member] | CAMP NYC, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 36,000 |  |
Investments at fair value |  | $ 40,000 |  |
Number of Shares (in shares) |  | 112,356 |  |
Preferred Stock Warrants [Member] | LiquiGlide, Inc [Member] | Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 39,000 |  |
Investments at fair value |  | $ 25,000 |  |
Number of Shares (in shares) |  | 61,359 |  |
Preferred Stock Warrants [Member] | Elligo Healthcare Research, Inc. [Member] | Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 191,000 |  |
Investments at fair value |  | $ 92,000 |  |
Number of Shares (in shares) |  | 652,250 |  |
Preferred Stock Warrants [Member] | Onkos Surgical, Inc. [Member] | Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 192,000 |  |
Investments at fair value |  | $ 187,000 |  |
Number of Shares (in shares) |  | 443,674 |  |
Preferred Stock Warrants [Member] | SIGNiX, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 225,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 186,235 |  |
Preferred Stock Warrants [Member] | Clara Foods Co [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 30,000 |  |
Investments at fair value |  | $ 43,000 |  |
Number of Shares (in shares) |  | 46,745 |  |
Preferred Stock Warrants [Member] | Pivot Bio, Inc. [Member] | Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 14,000 |  |
Investments at fair value |  | $ 14,000 |  |
Number of Shares (in shares) |  | 210,418 |  |
Preferred Stock Warrants [Member] | NextCar Holding Company, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 9,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 3,913,723 |  |
Preferred Stock Warrants [Member] | KSQ Therapeutics, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 50,000 |  |
Investments at fair value |  | $ 53,000 |  |
Number of Shares (in shares) |  | 48,076 |  |
Preferred Stock Warrants [Member] | Slingshot Aerospace, Inc. [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 123,000 |  |
Investments at fair value |  | $ 66,000 |  |
Number of Shares (in shares) |  | 309,208 |  |
Preferred Stock Warrants [Member] | Soli Organic, Inc [Member] | Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 382,000 |  |
Investments at fair value |  | $ 10,000 |  |
Number of Shares (in shares) |  | 1,075 |  |
Preferred Stock Warrants [Member] | Medsphere Systems Corporation [Member] | Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 60,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 7,097,792 |  |
Preferred Stock Warrants [Member] | Conventus Orthopaedics, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 256,000 |  |
Investments at fair value |  | $ 102,000 |  |
Number of Shares (in shares) |  | 9,313,541 |  |
Preferred Stock Warrants [Member] | Sonex Health, Inc. [Member] | Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 275,000 |  |
Investments at fair value |  | $ 266,000 |  |
Number of Shares (in shares) |  | 2,637,133 |  |
Preferred Stock Warrants [Member] | Supply Network Visiblity Holdings LLC [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 65,000 |  |
Investments at fair value |  | $ 75,000 |  |
Number of Shares (in shares) |  | 682 |  |
Preferred Stock Warrants [Member] | Divergent Technologies, Inc. [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 454,000 |  |
Investments at fair value |  | $ 440,000 |  |
Number of Shares (in shares) |  | 45,273 |  |
Preferred Stock Warrants [Member] | Temperpack Technologies, Inc [Member] | Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 178,000 |  |
Investments at fair value |  | $ 102,000 |  |
Number of Shares (in shares) |  | 49,693 |  |
Preferred Stock Warrants [Member] | SafelyYou, Inc [Member] | Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 163,000 |  |
Investments at fair value |  | $ 149,000 |  |
Number of Shares (in shares) |  | 150,353 |  |
Preferred Stock Warrants [Member] | Native Microbials, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 73,000 |  |
Investments at fair value |  | $ 68,000 |  |
Number of Shares (in shares) |  | 112,879 |  |
Preferred Stock Warrants [Member] | Topia Mobility, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 138,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 30,496 |  |
Preferred Stock Warrants [Member] | InfoBionic, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 231,000 |  |
Investments at fair value |  | $ 175,000 |  |
Number of Shares (in shares) |  | 5,361,130 |  |
Preferred Stock Warrants [Member] | Spineology, Inc [Member] | Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 16,000 |  |
Investments at fair value |  | $ 28,000 |  |
Number of Shares (in shares) |  | 2,255,155 |  |
Preferred Stock Warrants [Member] | Ursa Space Systems Inc. [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 151,000 |  |
Investments at fair value |  | $ 148,000 |  |
Number of Shares (in shares) |  | 1,075,072 |  |
Preferred Stock Warrants [Member] | Lemongrass Holdings, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 34,000 |  |
Investments at fair value |  | $ 48,000 |  |
Number of Shares (in shares) |  | 101,308 |  |
Preferred Stock Warrants [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 312,000 |  |
Investments at fair value |  | $ 59,000 |  |
Number of Shares (in shares) |  | 709,980 |  |
Preferred Stock Warrants [Member] | Viken Detection Corporation [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 120,000 |  |
Investments at fair value |  | $ 234,000 |  |
Number of Shares (in shares) |  | 345,443 |  |
Preferred Stock Warrants [Member] | Intelepeer Holdings, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 138,000 |  |
Investments at fair value |  | $ 3,156,000 |  |
Number of Shares (in shares) |  | 2,936,535 |  |
Preferred Stock Warrants [Member] | GT Medical Technologies, Inc. [Member] | Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 83,000 |  |
Investments at fair value |  | $ 95,000 |  |
Number of Shares (in shares) |  | 195,984 |  |
Preferred Stock Warrants [Member] | xAd, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 177,000 |  |
Investments at fair value |  | $ 6,000 |  |
Number of Shares (in shares) |  | 4,343,348 |  |
Preferred Stock Warrants [Member] | Alula Holdings, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 93,000 |  |
Investments at fair value |  | $ 7,000 |  |
Number of Shares (in shares) |  | 20,000 |  |
Preferred Stock Warrants [Member] | Tallac Therapeutics, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 194,000 |  |
Investments at fair value |  | $ 167,000 |  |
Number of Shares (in shares) |  | 1,600,002 |  |
Preferred Stock Warrants [Member] | Optoro, Inc. [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 182,000 |  |
Investments at fair value |  | $ 99,000 |  |
Number of Shares (in shares) |  | 11,550 |  |
Preferred Stock Warrants [Member] | Standvast Holdings, LLC [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 275,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 1,225,492 |  |
Preferred Stock Warrants [Member] | Aerin Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 65,000 |  |
Investments at fair value |  | $ 1,418,000 |  |
Number of Shares (in shares) |  | 1,818,183 |  |
Preferred Stock Warrants [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 48,000 |  |
Investments at fair value |  | $ 16,000 |  |
Number of Shares (in shares) |  | 8,800 |  |
Preferred Stock Warrants [Member] | Canary Medical Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 86,000 |  |
Investments at fair value |  | $ 2,000 |  |
Number of Shares (in shares) |  | 12,153 |  |
Preferred Stock Warrants [Member] | Unagi, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 32,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 171,081 |  |
Preferred Stock Warrants [Member] | MyForest Foods Co [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 29,000 |  |
Investments at fair value |  | $ 25,000 |  |
Number of Shares (in shares) |  | 250 |  |
Preferred Stock Warrants [Member] | Cognoa, Inc. [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 162,000 |  |
Investments at fair value |  | $ 1,000 |  |
Number of Shares (in shares) |  | 4,635,991 |  |
Preferred Stock Warrants [Member] | CSA Medical, Inc [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 174,000 |  |
Investments at fair value |  | $ 479,000 |  |
Number of Shares (in shares) |  | 4,917,794 |  |
Preferred Stock Warrants [Member] | Britecore Holdings, Inc. [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 98,000 |  |
Investments at fair value |  | $ 289,000 |  |
Number of Shares (in shares) |  | 161,215 |  |
Preferred Stock Warrants [Member] | Primary Kids, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 57,000 |  |
Investments at fair value |  | $ 412,000 |  |
Number of Shares (in shares) |  | 553,778 |  |
Preferred Stock Warrants [Member] | Quip NYC Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 325,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 6,191 |  |
Preferred Stock Warrants [Member] | Updater, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 34,000 |  |
Investments at fair value |  | $ 26,000 |  |
Number of Shares (in shares) |  | 108,333 |  |
Preferred Stock Warrants [Member] | CPG Beyond, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 242,000 |  |
Investments at fair value |  | $ 231,000 |  |
Number of Shares (in shares) |  | 500,000 |  |
Preferred Stock Warrants [Member] | Silk, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 175,000 |  |
Investments at fair value |  | $ 119,000 |  |
Number of Shares (in shares) |  | 394,110 |  |
Preferred Stock Warrants [Member] | Global Worldwide LLC [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 75,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 245,810 |  |
Preferred Stock Warrants [Member] | Rocket Lawyer Incorporated [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 92,000 |  |
Investments at fair value |  | $ 319,000 |  |
Number of Shares (in shares) |  | 261,721 |  |
Preferred Stock Warrants [Member] | Skillshare, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 162,000 |  |
Investments at fair value |  | $ 680,000 |  |
Number of Shares (in shares) |  | 139,074 |  |
Preferred Stock Warrants [Member] | Liqid, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 364,000 |  |
Investments at fair value |  | $ 103,000 |  |
Number of Shares (in shares) |  | 344,102 |  |
Preferred Stock Warrants [Member] | Avalanche Technology, Inc [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 45,000 |  |
Investments at fair value |  | $ 0 |  |
Number of Shares (in shares) |  | 5,938 |  |
Preferred Stock Warrants [Member] | Everstream Holdings, LLC [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 82,000 |  |
Investments at fair value |  | $ 34,000 |  |
Number of Shares (in shares) |  | 525,000 |  |
Other Investments, Prime Index, Two [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | $ 7,634,000 |  |
Investments at fair value |  | 2,832,000 |  |
Restricted Short Term Investments [Member] |  |  |  |
Investments at cost |  | 3,338,000 | 2,642,000 |
Investments at fair value |  | 3,338,000 | 2,642,000 |
Restricted Short Term Investments [Member] | U S Bank Money Market Deposit Account [Member] |  |  |  |
Investments at cost |  | 3,338,000 | 2,642,000 |
Investments at fair value |  | 3,338,000 | 2,642,000 |
Equity Securities [Member] |  |  |  |
Investments at cost |  | 35,942,000 | 14,443,000 |
Investments at fair value |  | 26,198,000 | 7,889,000 |
Equity Securities [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 9,653,000 | 6,132,000 |
Investments at fair value |  | 8,277,000 | 4,733,000 |
Equity Securities [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | 5,000,000 |  |
Investments at fair value |  | 0 |  |
Equity Securities [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  | 21,289,000 |  |
Investments at fair value |  | 17,921,000 |  |
Equity Securities [Member] | Technology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  |  | 3,311,000 |
Investments at fair value |  |  | 3,024,000 |
Equity Securities [Member] | Life Science [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  |  | 5,000,000 |
Investments at fair value |  |  | $ 132,000 |
Number of Shares (in shares) |  |  |  |
Debt Securities [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 660,556,000 | $ 692,345,000 |
Investments at fair value |  | 631,111,000 | 664,203,000 |
Debt Securities [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  | 17,611,000 |  |
Investments at fair value |  | 7,668,000 |  |
Debt Securities [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 263,280,000 |  |
Investments at fair value |  | 261,520,000 |  |
Debt Securities [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  |  | 5,335,000 |
Investments at fair value |  |  | 4,969,000 |
Debt Securities [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 222,699,000 | 275,026,000 |
Investments at fair value |  | 198,350,000 | 269,790,000 |
Debt Securities [Member] | Life Science [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | 249,642,000 |
Investments at fair value |  |  | 244,815,000 |
Debt Securities [Member] | Life Science [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  |  | 23,551,000 |
Investments at fair value |  |  | 1,000,000 |
Debt Securities [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 67,637,000 |  |
Investments at fair value |  | 67,052,000 |  |
Debt Securities [Member] | Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 106,940,000 | 69,770,000 |
Investments at fair value |  | $ 104,189,000 | 69,770,000 |
Debt Securities [Member] | Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | 97,907,000 |
Investments at fair value |  |  | $ 79,828,000 |
Debt Securities [Member] | Nexii Building Solutions, Inc [Member] | Other Sustainability Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 10.00% |  |
Floor |  | 0.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | Jul. 01, 2027 |  |
Principal Amount |  | $ 790,000 |  |
Investments at cost |  | 790,000 |  |
Investments at fair value |  | $ 638,000 |  |
Term Loan, Prime Index Three [Member] | DropOff, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 6.50% |  |
Floor |  | 9.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jun. 01, 2026 |  |
Principal Amount |  | $ 2,617,000 |  |
Investments at cost |  | 2,595,000 |  |
Investments at fair value |  | $ 2,449,000 |  |
Term Loan, Prime Index Three [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 6.00% |  |
Floor |  | 9.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jun. 01, 2026 |  |
Principal Amount |  | $ 3,214,000 |  |
Investments at cost |  | 3,151,000 |  |
Investments at fair value |  | $ 1,886,000 |  |
Term Loan, Prime Index Three [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.75% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | Aug. 01, 2025 |  |
Principal Amount |  | $ 538,000 |  |
Investments at cost |  | 538,000 |  |
Investments at fair value |  | $ 0 |  |
Term Loan, Prime Index Three [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.88% | 13.25% |
Margin |  | 5.13% | 4.75% |
Floor |  | 9.55% | 9.55% |
Ceiling |  | 13.50% | 13.50% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 2,000,000 | $ 3,000,000 |
Investments at cost |  | 1,996,000 | 2,987,000 |
Investments at fair value |  | $ 1,996,000 | $ 2,987,000 |
Term Loan, Prime Index Three [Member] | VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 3.75% |  |
Floor |  | 12.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,912,000 |  |
Investments at fair value |  | $ 4,912,000 |  |
Term Loan, Prime Index Three [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.00% |  |
Margin |  | 3.50% |  |
Floor |  | 10.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 7.78% |  |
Maturity Date |  | Feb. 01, 2028 |  |
Principal Amount |  | $ 2,813,000 |  |
Investments at cost |  | 2,813,000 |  |
Investments at fair value |  | $ 2,813,000 |  |
Term Loan, Prime Index Three [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.00% |  |
Margin |  | 5.50% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Apr. 01, 2026 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,978,000 |  |
Investments at fair value |  | $ 4,978,000 |  |
Term Loan, Prime Index Three [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.25% |  |
Margin |  | 5.50% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Aug. 01, 2027 |  |
Principal Amount |  | $ 3,500,000 |  |
Investments at cost |  | 3,477,000 |  |
Investments at fair value |  | $ 3,477,000 |  |
Term Loan, Prime Index Three [Member] | Axiom Space, Inc [Member] | Communications Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.75% |  |
Margin |  | 6.00% |  |
Floor |  | 9.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Jun. 01, 2026 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,731,000 |  |
Investments at fair value |  | $ 3,731,000 |  |
Term Loan, Prime Index Three [Member] | Noodle Partners, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.50% |  |
Margin |  | 5.00% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Mar. 01, 2027 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,964,000 |  |
Investments at fair value |  | $ 4,964,000 |  |
Term Loan, Prime Index Three [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  |  | 13.22% |
Margin |  |  | 4.72% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | Nov. 01, 2025 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,950,000 |
Investments at fair value |  |  | $ 4,950,000 |
Term Loan, Prime Index Three [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,934,000 |  |
Investments at fair value |  | $ 4,934,000 |  |
Term Loan, Prime Index Three [Member] | Elligo Healthcare Research, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2027 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,945,000 |  |
Investments at fair value |  | $ 4,945,000 |  |
Term Loan, Prime Index Three [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 5.75% |  |
Floor |  | 9.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.25% |  |
Maturity Date |  | Oct. 31, 2023 |  |
Principal Amount |  | $ 2,417,000 |  |
Investments at cost |  | 2,166,000 |  |
Investments at fair value |  | $ 508,000 |  |
Term Loan, Prime Index Three [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 10.25% |  |
Margin |  | 2.50% |  |
Floor |  | 2.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 9.14% |  |
Maturity Date |  | Jun. 01, 2028 |  |
Principal Amount |  | $ 1,948,000 |  |
Investments at cost |  | 1,922,000 |  |
Investments at fair value |  | $ 1,654,000 |  |
Term Loan, Prime Index Three [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.75% |  |
Maturity Date |  | May 01, 2026 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,922,000 |  |
Investments at fair value |  | $ 4,792,000 |  |
Term Loan, Prime Index Three [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 7,500,000 |  |
Investments at cost |  | 7,407,000 |  |
Investments at fair value |  | $ 7,407,000 |  |
Term Loan, Prime Index Three [Member] | PDS Biotechnology Corporation [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.25% | 14.25% |
Margin |  | 5.75% | 5.75% |
Floor |  | 9.75% | 9.75% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 3.75% | 3.75% |
Maturity Date |  | Sep. 01, 2026 | Sep. 01, 2026 |
Principal Amount |  | $ 3,281,000 | $ 3,750,000 |
Investments at cost |  | 3,267,000 | 3,717,000 |
Investments at fair value |  | $ 3,267,000 | $ 3,717,000 |
Term Loan, Prime Index Three [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.86% | 13.86% |
Margin |  | 5.36% | 5.36% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.31% | 5.50% |
Maturity Date |  | Jan. 01, 2027 | Dec. 01, 2024 |
Principal Amount |  | $ 1,741,000 | $ 2,333,000 |
Investments at cost |  | 1,705,000 | 2,281,000 |
Investments at fair value |  | $ 1,588,000 | 2,199,000 |
Term Loan, Prime Index Three [Member] | Viken Detection Corporation [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 4.00% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Jun. 01, 2027 |  |
Principal Amount |  | $ 2,417,000 |  |
Investments at cost |  | 2,396,000 |  |
Investments at fair value |  | $ 2,396,000 |  |
Term Loan, Prime Index Three [Member] | GT Medical Technologies, Inc. [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.25% |  |
Margin |  | 3.25% |  |
Floor |  | 11.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2029 |  |
Principal Amount |  | $ 7,500,000 |  |
Investments at cost |  | 7,389,000 |  |
Investments at fair value |  | $ 7,389,000 |  |
Term Loan, Prime Index Three [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 4.25% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Jun. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,494,000 |  |
Investments at fair value |  | $ 2,494,000 |  |
Term Loan, Prime Index Three [Member] | Hometeam Technologies, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.25% |  |
Margin |  | 3.25% |  |
Floor |  | 11.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Aug. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,954,000 |  |
Investments at fair value |  | $ 4,954,000 |  |
Term Loan, Prime Index Three [Member] | Standvast Holdings, LLC [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.75% |  |
Margin |  | 4.25% |  |
Floor |  | 12.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Nov. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,417,000 |  |
Investments at fair value |  | $ 2,343,000 |  |
Term Loan, Prime Index Three [Member] | Unagi, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 15.25% |  |
Margin |  | 7.75% |  |
Floor |  | 11.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | May 01, 2027 |  |
Principal Amount |  | $ 708,000 |  |
Investments at cost |  | 543,000 |  |
Investments at fair value |  | $ 0 |  |
Term Loan, Prime Index Three [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 5.50% |  |
Floor |  | 14.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,472,000 |  |
Investments at fair value |  | $ 2,472,000 |  |
Term Loan, Prime Index Three [Member] | Crafty Holdings, Inc.[Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 4.50% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,911,000 |  |
Investments at fair value |  | 4,911,000 |  |
Other Investments, Prime Index, Three [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | 2,946,000 |  |
Investments at fair value |  | 1,095,000 |  |
Warrant [Member] |  |  |  |
Investments at cost |  | 15,956,000 | 16,526,000 |
Investments at fair value |  | 18,277,000 | 24,594,000 |
Warrant [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 15,829,000 | 16,400,000 |
Investments at fair value |  | 18,277,000 | 24,594,000 |
Warrant [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | 127,000 | 126,000 |
Investments at fair value |  | 0 | 0 |
Warrant [Member] | Technology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | 9,733,000 |
Investments at fair value |  |  | 14,506,000 |
Warrant [Member] | Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 5,149,000 | 4,702,000 |
Investments at fair value |  | 6,374,000 | 7,675,000 |
Warrant [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | 999,000 |
Investments at fair value |  |  | $ 542,000 |
Number of Shares (in shares) |  |  |  |
Warrant [Member] | Healthcare Information and Services Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 1,047,000 | $ 966,000 |
Investments at fair value |  | 1,066,000 | 1,871,000 |
Warrant [Member] | Sustainability Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 715,000 |  |
Investments at fair value |  | 187,000 |  |
Warrant [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | 127,000 | 126,000 |
Investments at fair value |  | $ 0 | $ 0 |
Number of Shares (in shares) |  | 23,196 | 23,196 |
Other Investments [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | $ 8,465,000 |  |
Investments at fair value |  | 100,000 |  |
Other Investments [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | 22,364,000 |  |
Investments at fair value |  | 8,307,000 |  |
Other Investments [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  | 5,880,000 |  |
Investments at fair value |  | 6,230,000 |  |
Other Investments [Member] | Life Science [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  |  | $ 1,200,000 |
Investments at fair value |  |  | 200,000 |
Other Investments [Member] | Life Science [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  |  | 5,782,000 |
Investments at fair value |  |  | 6,230,000 |
Other Investments [Member] | HIMV LLC [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  | 5,880,000 |  |
Investments at fair value |  | $ 6,230,000 |  |
Other Investments [Member] | HIMV LLC [Member] | Life Science [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost |  |  | 5,782,000 |
Investments at fair value |  |  | $ 6,230,000 |
Term Loan, Prime Index, Four [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 0.00% |  |
Floor |  | 0.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 50.00% |  |
Maturity Date |  | Mar. 01, 2025 |  |
Principal Amount |  | $ 300,000 |  |
Investments at cost |  | 300,000 |  |
Investments at fair value |  | $ 180,000 |  |
Term Loan, Prime Index, Four [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.75% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | Aug. 01, 2025 |  |
Principal Amount |  | $ 532,000 |  |
Investments at cost |  | 532,000 |  |
Investments at fair value |  | $ 0 |  |
Term Loan, Prime Index, Four [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.88% | 13.25% |
Margin |  | 5.13% | 4.75% |
Floor |  | 9.55% | 9.55% |
Ceiling |  | 13.50% | 13.50% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 3,333,000 | $ 5,000,000 |
Investments at cost |  | 3,326,000 | 4,979,000 |
Investments at fair value |  | $ 3,326,000 | $ 4,979,000 |
Term Loan, Prime Index, Four [Member] | VERO Biotech LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.25% |  |
Margin |  | 3.75% |  |
Floor |  | 12.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,456,000 |  |
Investments at fair value |  | $ 2,456,000 |  |
Term Loan, Prime Index, Four [Member] | Havenly, Inc. [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.00% |  |
Margin |  | 3.50% |  |
Floor |  | 10.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 7.78% |  |
Maturity Date |  | Feb. 01, 2028 |  |
Principal Amount |  | $ 2,813,000 |  |
Investments at cost |  | 2,813,000 |  |
Investments at fair value |  | $ 2,813,000 |  |
Term Loan, Prime Index, Four [Member] | Kodiak Robotics, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.00% |  |
Margin |  | 5.50% |  |
Floor |  | 10.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Apr. 01, 2026 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,978,000 |  |
Investments at fair value |  | $ 4,978,000 |  |
Term Loan, Prime Index, Four [Member] | BrightInsight, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.25% |  |
Margin |  | 5.50% |  |
Floor |  | 9.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 2,750,000 |  |
Investments at cost |  | 2,719,000 |  |
Investments at fair value |  | $ 2,719,000 |  |
Term Loan, Prime Index, Four [Member] | Emalex Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  |  | 13.22% |
Margin |  |  | 4.72% |
Floor |  |  | 9.75% |
Ceiling |  |  | 0.00% |
ETP |  |  | 5.00% |
Maturity Date |  |  | May 01, 2026 |
Principal Amount |  |  | $ 5,000,000 |
Investments at cost |  |  | 4,949,000 |
Investments at fair value |  |  | $ 4,949,000 |
Term Loan, Prime Index, Four [Member] | Mirantis, Inc [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,934,000 |  |
Investments at fair value |  | $ 4,934,000 |  |
Term Loan, Prime Index, Four [Member] | Elligo Healthcare Research, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.75% |  |
Margin |  | 3.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date |  | Oct. 01, 2027 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,945,000 |  |
Investments at fair value |  | $ 4,945,000 |  |
Term Loan, Prime Index, Four [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 5.75% |  |
Floor |  | 9.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.25% |  |
Maturity Date |  | Oct. 31, 2023 |  |
Principal Amount |  | $ 3,021,000 |  |
Investments at cost |  | 2,707,000 |  |
Investments at fair value |  | $ 635,000 |  |
Term Loan, Prime Index, Four [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 10.25% |  |
Margin |  | 2.50% |  |
Floor |  | 2.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 9.14% |  |
Maturity Date |  | Jun. 01, 2028 |  |
Principal Amount |  | $ 1,948,000 |  |
Investments at cost |  | 1,922,000 |  |
Investments at fair value |  | $ 1,654,000 |  |
Term Loan, Prime Index, Four [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.75% |  |
Maturity Date |  | May 01, 2026 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,461,000 |  |
Investments at fair value |  | $ 2,396,000 |  |
Term Loan, Prime Index, Four [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,704,000 |  |
Investments at fair value |  | $ 3,704,000 |  |
Term Loan, Prime Index, Four [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.86% | 13.86% |
Margin |  | 5.36% | 5.36% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.31% | 5.50% |
Maturity Date |  | Jan. 01, 2027 | Dec. 01, 2024 |
Principal Amount |  | $ 1,741,000 | $ 2,333,000 |
Investments at cost |  | 1,705,000 | 2,281,000 |
Investments at fair value |  | $ 1,588,000 | $ 2,199,000 |
Term Loan, Prime Index, Four [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 4.25% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Jun. 01, 2028 |  |
Principal Amount |  | $ 1,500,000 |  |
Investments at cost |  | 1,496,000 |  |
Investments at fair value |  | $ 1,496,000 |  |
Term Loan, Prime Index, Four [Member] | Hometeam Technologies, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.25% |  |
Margin |  | 3.25% |  |
Floor |  | 11.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Aug. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,954,000 |  |
Investments at fair value |  | $ 4,954,000 |  |
Term Loan, Prime Index, Four [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 5.50% |  |
Floor |  | 14.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Oct. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,472,000 |  |
Investments at fair value |  | 2,472,000 |  |
Other Investments, Prime Index, Four [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | 2,946,000 |  |
Investments at fair value |  | $ 1,095,000 |  |
Term Loan, Prime Index, Five [Member] | Hound Labs, Inc. [Member] | Diagnostics Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 0.00% |  |
Floor |  | 0.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 100.00% |  |
Maturity Date |  | Mar. 01, 2025 |  |
Principal Amount |  | $ 250,000 |  |
Investments at cost |  | 250,000 |  |
Investments at fair value |  | $ 150,000 |  |
Term Loan, Prime Index, Five [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.75% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | Aug. 01, 2025 |  |
Principal Amount |  | $ 521,000 |  |
Investments at cost |  | 521,000 |  |
Investments at fair value |  | $ 0 |  |
Term Loan, Prime Index, Five [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.88% | 13.25% |
Margin |  | 5.13% | 4.75% |
Floor |  | 9.55% | 9.55% |
Ceiling |  | 13.50% | 13.50% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 3,333,000 | $ 5,000,000 |
Investments at cost |  | 3,326,000 | 4,979,000 |
Investments at fair value |  | $ 3,326,000 | $ 4,979,000 |
Term Loan, Prime Index, Five [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 5.75% |  |
Floor |  | 9.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.25% |  |
Maturity Date |  | Oct. 31, 2023 |  |
Principal Amount |  | $ 3,625,000 |  |
Investments at cost |  | 3,249,000 |  |
Investments at fair value |  | $ 762,000 |  |
Term Loan, Prime Index, Five [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 10.25% |  |
Margin |  | 2.50% |  |
Floor |  | 2.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 100.00% |  |
Maturity Date |  | Jun. 01, 2028 |  |
Principal Amount |  | $ 315,000 |  |
Investments at cost |  | 315,000 |  |
Investments at fair value |  | $ 271,000 |  |
Term Loan, Prime Index, Five [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.00% |  |
Margin |  | 5.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.75% |  |
Maturity Date |  | Dec. 01, 2026 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,925,000 |  |
Investments at fair value |  | $ 4,795,000 |  |
Term Loan, Prime Index, Five [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,704,000 |  |
Investments at fair value |  | $ 3,704,000 |  |
Term Loan, Prime Index, Five [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.86% | 13.86% |
Margin |  | 5.36% | 5.36% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.31% | 5.50% |
Maturity Date |  | Jan. 01, 2027 | Dec. 01, 2024 |
Principal Amount |  | $ 1,741,000 | $ 2,333,000 |
Investments at cost |  | 1,704,000 | 2,278,000 |
Investments at fair value |  | $ 1,587,000 | $ 2,196,000 |
Term Loan, Prime Index, Five [Member] | Supply Network Visibility Holdings, LLC [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 4.25% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Jul. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,984,000 |  |
Investments at fair value |  | $ 4,984,000 |  |
Term Loan, Prime Index, Five [Member] | Hometeam Technologies, Inc [Member] | Other Healthcare Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 11.25% |  |
Margin |  | 3.25% |  |
Floor |  | 11.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.50% |  |
Maturity Date |  | Aug. 01, 2029 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,954,000 |  |
Investments at fair value |  | $ 4,954,000 |  |
Term Loan, Prime Index, Five [Member] | Britecore Holdings, Inc. [Member] | Software Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 14.00% |  |
Margin |  | 5.50% |  |
Floor |  | 14.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 3.00% |  |
Maturity Date |  | Apr. 01, 2029 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,469,000 |  |
Investments at fair value |  | 2,469,000 |  |
Other Investments, Prime Index, Five [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | 1,964,000 |  |
Investments at fair value |  | $ 730,000 |  |
Term Loan, Prime Index, Six [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.75% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | Aug. 01, 2025 |  |
Principal Amount |  | $ 513,000 |  |
Investments at cost |  | 513,000 |  |
Investments at fair value |  | $ 0 |  |
Term Loan, Prime Index, Six [Member] | Castle Creek Biosciences, Inc [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.88% | 13.25% |
Margin |  | 5.13% | 4.75% |
Floor |  | 9.55% | 9.55% |
Ceiling |  | 13.50% | 13.50% |
ETP |  | 5.50% | 5.50% |
Maturity Date |  | May 01, 2026 | May 01, 2026 |
Principal Amount |  | $ 2,000,000 | $ 3,000,000 |
Investments at cost |  | 1,996,000 | 2,987,000 |
Investments at fair value |  | $ 1,996,000 | $ 2,987,000 |
Term Loan, Prime Index, Six [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 5.75% |  |
Floor |  | 9.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.25% |  |
Maturity Date |  | Oct. 31, 2023 |  |
Principal Amount |  | $ 3,021,000 |  |
Investments at cost |  | 2,707,000 |  |
Investments at fair value |  | $ 635,000 |  |
Term Loan, Prime Index, Six [Member] | Swift Health Systems Inc. [Member] | Medical Device Sector [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 10.25% |  |
Margin |  | 2.50% |  |
Floor |  | 2.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 100.00% |  |
Maturity Date |  | Jun. 01, 2028 |  |
Principal Amount |  | $ 156,000 |  |
Investments at cost |  | 156,000 |  |
Investments at fair value |  | $ 135,000 |  |
Term Loan, Prime Index, Six [Member] | Soli Organic, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.00% |  |
Margin |  | 5.50% |  |
Floor |  | 11.75% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.75% |  |
Maturity Date |  | Dec. 01, 2026 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,462,000 |  |
Investments at fair value |  | $ 2,397,000 |  |
Term Loan, Prime Index, Six [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 6.00% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 4,500,000 |  |
Investments at cost |  | 4,454,000 |  |
Investments at fair value |  | $ 4,454,000 |  |
Term Loan, Prime Index, Six [Member] | Provivi, Inc. [Member] | Biotechnology Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 12.86% | 13.86% |
Margin |  | 5.36% | 5.36% |
Floor |  | 9.50% | 9.50% |
Ceiling |  | 0.00% | 0.00% |
ETP |  | 4.31% | 5.50% |
Maturity Date |  | Jan. 01, 2027 | Dec. 01, 2024 |
Principal Amount |  | $ 1,741,000 | $ 2,333,000 |
Investments at cost |  | 1,704,000 | 2,278,000 |
Investments at fair value |  | 1,587,000 | $ 2,196,000 |
Other Investments, Prime Index, Six [Member] | Evelo Biosciences, Inc. [Member] | Biotechnology Sector [Member] | Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost |  | 1,964,000 |  |
Investments at fair value |  | $ 730,000 |  |
Term Loan, Prime Index, Seven [Member] | Better Place Forests Co. [Member] | Consumer-related Technologies [Member] | Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Cash Rate |  | 12.00% |  |
Margin |  | 3.75% |  |
Floor |  | 12.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 0.00% |  |
Maturity Date |  | Aug. 01, 2025 |  |
Principal Amount |  | $ 505,000 |  |
Investments at cost |  | 505,000 |  |
Investments at fair value |  | $ 0 |  |
Term Loan, Prime Index, Seven [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 5.75% |  |
Floor |  | 9.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.25% |  |
Maturity Date |  | Oct. 31, 2023 |  |
Principal Amount |  | $ 6,042,000 |  |
Investments at cost |  | 5,415,000 |  |
Investments at fair value |  | $ 1,271,000 |  |
Term Loan, Prime Index, Seven [Member] | Temperpack Technologies, Inc [Member] | Other Sustainability Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 6.00% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.00% |  |
Maturity Date |  | Jan. 01, 2029 |  |
Principal Amount |  | $ 2,000,000 |  |
Investments at cost |  | 1,980,000 |  |
Investments at fair value |  | $ 1,980,000 |  |
Term Loan, Prime Index, Eight [Member] | NextCar Holding Company, Inc [Member] | Consumer-related Technologies [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 13.50% |  |
Margin |  | 5.75% |  |
Floor |  | 9.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.25% |  |
Maturity Date |  | Oct. 31, 2023 |  |
Principal Amount |  | $ 3,021,000 |  |
Investments at cost |  | 2,707,000 |  |
Investments at fair value |  | 635,000 |  |
Royalty Agreement [Member] | Robin Healthcare, Inc. [Member] | Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 7,319,000 |  |
Investments at fair value |  | 0 |  |
Royalty Agreement [Member] | Lumithera, Inc. [Member] | Life Science Segment [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 1,146,000 |  |
Investments at fair value |  | $ 100,000 |  |
Term Loan, Fixed Index One [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 9.00% |  |
Margin |  | 0.00% |  |
Floor |  | 0.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 18.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,480,000 |  |
Investments at fair value |  | $ 2,085,000 |  |
Term Loan, Fixed Index Two [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 9.00% |  |
Margin |  | 0.00% |  |
Floor |  | 0.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 18.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,480,000 |  |
Investments at fair value |  | $ 2,085,000 |  |
Term Loan, Fixed Index Three [Member] | Aerobiotix, LLC [Member] | Medical Device Sector [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Cash Rate |  | 9.00% |  |
Margin |  | 0.00% |  |
Floor |  | 0.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 18.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 200,000 |  |
Investments at cost |  | 190,000 |  |
Investments at fair value |  | 160,000 |  |
Preferred Stock 2 [Member] | Lotame Solutions, Inc. [Member] | Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost |  | 29,000 |  |
Investments at fair value |  | $ 29,000 |  |
Number of Shares (in shares) |  | 9,381 |  |
[1] | As of December 31, 2023, the Company no longer owns 5% of more of the portfolio company.

X
- Definition The ceiling rate of the investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedCeilingRate
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The end of term payment rate (ETP) on investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedEndOfTermPaymentsETP
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage added to reference rate used to compute variable rate on investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentBasisSpreadVariableRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Minimum rate of interest on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRateFloor
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Rate of interest paid in cash on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRatePaidInCash
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Maturity date of investment, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Definition Cost of the investment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 19 -Subparagraph (3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of investment in security owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(11)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-2 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12 Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of principal of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of shares of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerControlledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DiagnosticsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_BiotechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_MedicalDeviceSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_TechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_CommunicationsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherSustainabilitySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherHealthcareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_EnergyEfficiencyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_NetworkingSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DataStorageSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_InternetAndMediaSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_PowerManagementSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SemiconductorSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareHealthcareInformationAndServiceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DropOffIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HoundLabsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_PreferredStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EveloBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AuleaMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BetterPlaceForestsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_ConsumerrelatedTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CastleCreekBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CandesantBiomedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VeroBiotechLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HavenlyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KodiakRoboticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BrightinsightIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RobinHealthcareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AxiomSpaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ParseBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvaloTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MagnoliaMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NoodlePartnersIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MeditrinaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ScientiaVascularIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_Engage3LLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NewAerofarmsIncAssigneeOfAerofarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KateFarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HIMVLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CeribellIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EmalexBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MicroTransponderIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RevinateHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexNineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexElevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwelveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CampNYCIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiquiglideIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyricalFoodsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MirantisIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ImunonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OnkosSurgicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SignixIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ClaraFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ElligoHealthResearchIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NextcarHoldingCompanyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KSQTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SlingshotAerospaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SwiftHealthSystemsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SoliOrganicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MedsphereSystemsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ConventusOrthopaedicsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MustangBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SonexHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DivergentTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TemperpackTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SafelyYouIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NativeMicrobialsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TopiaMobilityIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_InfobionicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PDSBiotechnologyCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SpineologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LemongrassHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ProviviIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VikenDetectionCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_IntelepeerHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LumitheraIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_RoyaltyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XadIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PebblepostIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ZetrozIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisibilityHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_StealthBioTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AlulaHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TallacTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AterianIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CadrenalTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OptoroIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XerisPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CaastleIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AccuveinIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerinMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerobiotixLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CZVIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CanaryMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UnagiIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MyforestFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CognoaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ReputationInstituteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CSAMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LotameSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BritecoreHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CVRXIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PrimaryKidsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_QuipNycIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UpdaterIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CPGBeyondIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SilkIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GlobalWorldwideLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RocketLawyerIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SkillshareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiqidIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HalioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvalancheTechnologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ELaCarteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EverstreamHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_UnrestrictedShortTermInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_USBankMoneyMarketDepositAccountMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GetaroundIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SnagajobcomIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TigoEnergyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OneNetworksIncdbaFinexioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ElligoHealthcareResearchIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PivotBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerofarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GreenlightBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UrsaSpaceSystemsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GTMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HometeamTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_StandvastHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_FictivIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CraftyHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DecisyonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_HealthcareInformationAndServicesSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SustainabilitySegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_PreferredStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisiblityHoldingsLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_RestrictedShortTermInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_OtherInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_RoyaltyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanFixedIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanFixedIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanFixedIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_PreferredStock2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |